Gene Symbol | Gene ID | Gene Info |
---|---|---|
Ebf1
|
ENSMUSG00000078561.3 | early B cell factor 1 |
Ebf1
|
ENSMUSG00000057098.8 | early B cell factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_44616647_44617708 | Ebf1 | 140 | 0.523585 | 0.51 | 3.0e-05 | Click! |
chr11_44618756_44619114 | Ebf1 | 756 | 0.571826 | 0.50 | 4.0e-05 | Click! |
chr11_44925250_44925401 | Ebf1 | 13187 | 0.288267 | 0.45 | 2.7e-04 | Click! |
chr11_44619749_44620587 | Ebf1 | 1593 | 0.328645 | 0.43 | 6.7e-04 | Click! |
chr11_44618206_44618424 | Ebf1 | 136 | 0.933808 | 0.40 | 1.8e-03 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr5_75148315_75152589 | 12.67 |
Pdgfra |
platelet derived growth factor receptor, alpha polypeptide |
1840 |
0.2 |
chr14_28508967_28511864 | 8.06 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
203 |
0.89 |
chr13_55835316_55837389 | 8.04 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
160 |
0.62 |
chr5_37826544_37829286 | 8.01 |
Msx1 |
msh homeobox 1 |
3332 |
0.25 |
chr1_162217585_162219370 | 7.72 |
Dnm3os |
dynamin 3, opposite strand |
601 |
0.46 |
chr11_85838795_85841602 | 7.46 |
Tbx2 |
T-box 2 |
7647 |
0.13 |
chr8_57320946_57324000 | 6.82 |
Hand2os1 |
Hand2, opposite strand 1 |
1245 |
0.3 |
chr4_114907257_114907947 | 6.62 |
Foxd2 |
forkhead box D2 |
1271 |
0.3 |
chr8_121116214_121118487 | 6.48 |
Foxc2 |
forkhead box C2 |
1179 |
0.35 |
chr11_18870055_18872175 | 6.45 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
1040 |
0.49 |
chr3_87949543_87950464 | 6.41 |
Crabp2 |
cellular retinoic acid binding protein II |
1337 |
0.25 |
chr11_85829139_85831432 | 6.20 |
2610027K06Rik |
RIKEN cDNA 2610027K06 gene |
1924 |
0.21 |
chr2_33629896_33632414 | 5.98 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
1128 |
0.43 |
chr13_55830047_55831334 | 5.98 |
Pitx1 |
paired-like homeodomain transcription factor 1 |
735 |
0.57 |
chr1_19215607_19218714 | 5.86 |
Tfap2b |
transcription factor AP-2 beta |
3281 |
0.25 |
chr3_66977838_66980287 | 5.76 |
Shox2 |
short stature homeobox 2 |
251 |
0.9 |
chr8_121118797_121121438 | 5.64 |
Foxc2 |
forkhead box C2 |
3946 |
0.14 |
chr13_71962692_71964069 | 5.42 |
Irx1 |
Iroquois homeobox 1 |
343 |
0.91 |
chr2_172549301_172551909 | 5.31 |
Tfap2c |
transcription factor AP-2, gamma |
48 |
0.98 |
chr8_92960352_92961533 | 5.21 |
Slc6a2 |
solute carrier family 6 (neurotransmitter transporter, noradrenalin), member 2 |
9 |
0.97 |
chr12_33961784_33963046 | 5.20 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
4744 |
0.25 |
chr4_83050960_83052655 | 5.10 |
Frem1 |
Fras1 related extracellular matrix protein 1 |
360 |
0.89 |
chr7_142660049_142661342 | 5.06 |
Igf2 |
insulin-like growth factor 2 |
510 |
0.56 |
chr8_87938260_87939386 | 5.06 |
Zfp423 |
zinc finger protein 423 |
5229 |
0.29 |
chr19_5821858_5822796 | 5.04 |
Gm27702 |
predicted gene, 27702 |
2380 |
0.12 |
chr5_134945425_134947032 | 4.90 |
Cldn4 |
claudin 4 |
706 |
0.44 |
chr12_73039135_73040425 | 4.83 |
Six1 |
sine oculis-related homeobox 1 |
3035 |
0.27 |
chr5_67095606_67096884 | 4.76 |
Phox2b |
paired-like homeobox 2b |
2812 |
0.22 |
chr5_37821115_37822599 | 4.74 |
Msx1 |
msh homeobox 1 |
2725 |
0.28 |
chr2_33639069_33641423 | 4.71 |
Lmx1b |
LIM homeobox transcription factor 1 beta |
234 |
0.85 |
chr1_24196799_24197314 | 4.64 |
Col9a1 |
collagen, type IX, alpha 1 |
39 |
0.98 |
chr5_119838900_119840891 | 4.55 |
Tbx5 |
T-box 5 |
3740 |
0.21 |
chr13_63557270_63560459 | 4.53 |
Ptch1 |
patched 1 |
4951 |
0.16 |
chr6_72233456_72234176 | 4.50 |
Atoh8 |
atonal bHLH transcription factor 8 |
721 |
0.64 |
chr17_85684987_85686256 | 4.42 |
Six2 |
sine oculis-related homeobox 2 |
2633 |
0.25 |
chr17_85686512_85689764 | 4.41 |
Six2 |
sine oculis-related homeobox 2 |
116 |
0.96 |
chr2_93646848_93647992 | 4.41 |
Alx4 |
aristaless-like homeobox 4 |
5032 |
0.27 |
chr8_57326741_57329467 | 4.36 |
Hand2os1 |
Hand2, opposite strand 1 |
3871 |
0.15 |
chr2_32750921_32752008 | 4.31 |
Tor2a |
torsin family 2, member A |
5770 |
0.08 |
chr17_67949642_67951057 | 4.31 |
Arhgap28 |
Rho GTPase activating protein 28 |
591 |
0.83 |
chr3_129223881_129225649 | 4.30 |
Gm43697 |
predicted gene 43697 |
763 |
0.61 |
chr17_93201490_93204144 | 4.25 |
Adcyap1 |
adenylate cyclase activating polypeptide 1 |
741 |
0.65 |
chr16_44549984_44550455 | 4.25 |
Mir3081 |
microRNA 3081 |
7910 |
0.21 |
chr13_54737787_54738662 | 4.21 |
Gprin1 |
G protein-regulated inducer of neurite outgrowth 1 |
11445 |
0.12 |
chr8_107545084_107547731 | 4.20 |
Wwp2 |
WW domain containing E3 ubiquitin protein ligase 2 |
1395 |
0.4 |
chr4_102978416_102979615 | 4.16 |
Tctex1d1 |
Tctex1 domain containing 1 |
324 |
0.86 |
chr4_57846607_57847875 | 4.12 |
Pakap |
paralemmin A kinase anchor protein |
1993 |
0.34 |
chr7_132153665_132154737 | 4.08 |
Gm15677 |
predicted gene 15677 |
30 |
0.88 |
chr9_41611530_41612990 | 4.04 |
Gm48737 |
predicted gene, 48737 |
6732 |
0.12 |
chr6_84584705_84586412 | 4.04 |
Cyp26b1 |
cytochrome P450, family 26, subfamily b, polypeptide 1 |
2122 |
0.4 |
chr11_85833878_85836704 | 4.02 |
Tbx2 |
T-box 2 |
2740 |
0.17 |
chr2_9882196_9886301 | 4.01 |
9230102O04Rik |
RIKEN cDNA 9230102O04 gene |
255 |
0.84 |
chr1_78196315_78197419 | 3.99 |
Pax3 |
paired box 3 |
29 |
0.98 |
chr10_107483887_107486076 | 3.98 |
Myf5 |
myogenic factor 5 |
1153 |
0.46 |
chr13_63278777_63280117 | 3.97 |
Gm47602 |
predicted gene, 47602 |
223 |
0.69 |
chr14_55826099_55826996 | 3.94 |
Nfatc4 |
nuclear factor of activated T cells, cytoplasmic, calcineurin dependent 4 |
491 |
0.63 |
chr7_142662290_142664788 | 3.93 |
Igf2os |
insulin-like growth factor 2, opposite strand |
1599 |
0.21 |
chr2_24678941_24679728 | 3.91 |
Gm13459 |
predicted gene 13459 |
4633 |
0.19 |
chr17_46444584_46445824 | 3.89 |
Gm5093 |
predicted gene 5093 |
5107 |
0.11 |
chr4_154635108_154637998 | 3.89 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr8_92361507_92362918 | 3.89 |
Irx5 |
Iroquois homeobox 5 |
4463 |
0.2 |
chr12_9578132_9580204 | 3.88 |
Osr1 |
odd-skipped related transcription factor 1 |
4727 |
0.2 |
chr2_93644408_93646515 | 3.88 |
Alx4 |
aristaless-like homeobox 4 |
3073 |
0.32 |
chr16_17797005_17798693 | 3.85 |
Scarf2 |
scavenger receptor class F, member 2 |
499 |
0.64 |
chr17_85679503_85681370 | 3.84 |
Six2 |
sine oculis-related homeobox 2 |
7818 |
0.18 |
chr12_112301510_112302123 | 3.82 |
Gm38123 |
predicted gene, 38123 |
48251 |
0.12 |
chr9_71215350_71216642 | 3.82 |
Aldh1a2 |
aldehyde dehydrogenase family 1, subfamily A2 |
207 |
0.95 |
chr2_165594861_165596083 | 3.81 |
Eya2 |
EYA transcriptional coactivator and phosphatase 2 |
440 |
0.82 |
chr2_74745819_74748448 | 3.79 |
Hoxd3 |
homeobox D3 |
1411 |
0.17 |
chr5_119830922_119832010 | 3.78 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chr12_9580218_9581715 | 3.78 |
Osr1 |
odd-skipped related transcription factor 1 |
6525 |
0.19 |
chr15_102258548_102259269 | 3.78 |
Rarg |
retinoic acid receptor, gamma |
1391 |
0.23 |
chr11_65269494_65270784 | 3.77 |
Myocd |
myocardin |
150 |
0.96 |
chr7_143106768_143108439 | 3.76 |
Kcnq1 |
potassium voltage-gated channel, subfamily Q, member 1 |
52 |
0.95 |
chr1_191184645_191186177 | 3.76 |
Atf3 |
activating transcription factor 3 |
2071 |
0.24 |
chr8_57317953_57318771 | 3.74 |
Hand2os1 |
Hand2, opposite strand 1 |
462 |
0.73 |
chr15_35302239_35303258 | 3.73 |
Osr2 |
odd-skipped related 2 |
2448 |
0.29 |
chr9_87729583_87731038 | 3.73 |
Tbx18 |
T-box18 |
187 |
0.9 |
chr9_41326803_41329121 | 3.72 |
Mir100hg |
Mir100 Mirlet7a-2 Mir125b-1 cluster host gene |
676 |
0.69 |
chr7_137309191_137310700 | 3.71 |
Ebf3 |
early B cell factor 3 |
3971 |
0.23 |
chr19_59470927_59471740 | 3.71 |
Emx2 |
empty spiracles homeobox 2 |
8531 |
0.16 |
chr17_85683384_85684714 | 3.71 |
Six2 |
sine oculis-related homeobox 2 |
4205 |
0.2 |
chr4_154632829_154634203 | 3.70 |
Prdm16 |
PR domain containing 16 |
3281 |
0.16 |
chr19_43384488_43385701 | 3.69 |
Hpse2 |
heparanase 2 |
3160 |
0.24 |
chr12_73044500_73046647 | 3.68 |
Six1 |
sine oculis-related homeobox 1 |
282 |
0.92 |
chr6_127252246_127252566 | 3.67 |
Gm43635 |
predicted gene 43635 |
2238 |
0.21 |
chr9_102267198_102267740 | 3.67 |
Gm37260 |
predicted gene, 37260 |
6267 |
0.21 |
chr5_113799288_113800716 | 3.66 |
Tmem119 |
transmembrane protein 119 |
444 |
0.69 |
chr3_99240695_99241824 | 3.66 |
Tbx15 |
T-box 15 |
878 |
0.53 |
chr11_116693809_116695037 | 3.66 |
St6galnac2 |
ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2 |
186 |
0.89 |
chr8_70493071_70496051 | 3.64 |
Crlf1 |
cytokine receptor-like factor 1 |
1200 |
0.25 |
chr5_24321335_24322296 | 3.61 |
Kcnh2 |
potassium voltage-gated channel, subfamily H (eag-related), member 2 |
439 |
0.73 |
chr14_28505401_28506870 | 3.61 |
Wnt5a |
wingless-type MMTV integration site family, member 5A |
235 |
0.93 |
chr11_90032564_90033760 | 3.60 |
Tmem100 |
transmembrane protein 100 |
2814 |
0.31 |
chr11_85836730_85838643 | 3.60 |
Tbx2 |
T-box 2 |
5135 |
0.14 |
chr9_105827743_105828681 | 3.59 |
Col6a6 |
collagen, type VI, alpha 6 |
52 |
0.98 |
chr8_57324709_57326732 | 3.59 |
Hand2os1 |
Hand2, opposite strand 1 |
1487 |
0.3 |
chr11_96365680_96367114 | 3.58 |
Hoxb1 |
homeobox B1 |
139 |
0.91 |
chr3_49753928_49755610 | 3.58 |
Pcdh18 |
protocadherin 18 |
695 |
0.72 |
chr9_32542191_32543480 | 3.57 |
Fli1 |
Friend leukemia integration 1 |
26 |
0.96 |
chr17_45619118_45620095 | 3.56 |
Gm25008 |
predicted gene, 25008 |
1073 |
0.33 |
chr3_99254836_99255604 | 3.56 |
Tbx15 |
T-box 15 |
1460 |
0.36 |
chr2_74691003_74692289 | 3.55 |
Hoxd10 |
homeobox D10 |
278 |
0.7 |
chr1_135507863_135508570 | 3.55 |
Nav1 |
neuron navigator 1 |
2168 |
0.24 |
chr2_28465731_28466642 | 3.53 |
1700007K13Rik |
RIKEN cDNA 1700007K13 gene |
130 |
0.92 |
chr2_26507235_26508363 | 3.51 |
Notch1 |
notch 1 |
3975 |
0.13 |
chr8_121088119_121090419 | 3.51 |
Gm27530 |
predicted gene, 27530 |
4563 |
0.13 |
chr17_56123820_56124985 | 3.48 |
Lrg1 |
leucine-rich alpha-2-glycoprotein 1 |
2401 |
0.13 |
chr6_52164011_52165366 | 3.48 |
Hoxa2 |
homeobox A2 |
143 |
0.83 |
chr14_55782680_55784401 | 3.43 |
Adcy4 |
adenylate cyclase 4 |
146 |
0.88 |
chr4_154170691_154171590 | 3.43 |
Megf6 |
multiple EGF-like-domains 6 |
410 |
0.77 |
chr12_33956740_33957445 | 3.43 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
579 |
0.78 |
chr16_31545699_31546726 | 3.41 |
Gm46560 |
predicted gene, 46560 |
37825 |
0.12 |
chr1_188660237_188661369 | 3.40 |
Gm25095 |
predicted gene, 25095 |
37750 |
0.21 |
chr18_75372210_75374418 | 3.40 |
Smad7 |
SMAD family member 7 |
1600 |
0.41 |
chr10_80808405_80809494 | 3.38 |
Jsrp1 |
junctional sarcoplasmic reticulum protein 1 |
2936 |
0.1 |
chr13_48664673_48666478 | 3.38 |
Barx1 |
BarH-like homeobox 1 |
2577 |
0.26 |
chr4_134237503_134238650 | 3.38 |
Cnksr1 |
connector enhancer of kinase suppressor of Ras 1 |
263 |
0.8 |
chr9_20972154_20973375 | 3.38 |
S1pr2 |
sphingosine-1-phosphate receptor 2 |
1214 |
0.26 |
chr2_33717798_33718695 | 3.37 |
9430024E24Rik |
RIKEN cDNA 9430024E24 gene |
653 |
0.72 |
chr9_55543267_55546069 | 3.36 |
Isl2 |
insulin related protein 2 (islet 2) |
2332 |
0.22 |
chr17_34671242_34672659 | 3.35 |
Tnxb |
tenascin XB |
1415 |
0.18 |
chr13_40744208_40745266 | 3.35 |
Tfap2a |
transcription factor AP-2, alpha |
6361 |
0.11 |
chr15_97990063_97991124 | 3.35 |
Col2a1 |
collagen, type II, alpha 1 |
117 |
0.96 |
chr9_114560970_114561936 | 3.35 |
Trim71 |
tripartite motif-containing 71 |
2916 |
0.23 |
chr5_147304305_147307985 | 3.34 |
Cdx2 |
caudal type homeobox 2 |
1125 |
0.33 |
chr3_145648599_145649990 | 3.34 |
Ccn1 |
cellular communication network factor 1 |
687 |
0.54 |
chr1_167691828_167693129 | 3.34 |
Lmx1a |
LIM homeobox transcription factor 1 alpha |
2921 |
0.37 |
chr3_87947557_87949450 | 3.33 |
Crabp2 |
cellular retinoic acid binding protein II |
163 |
0.9 |
chr17_28348327_28348971 | 3.33 |
Tead3 |
TEA domain family member 3 |
1697 |
0.21 |
chr4_57567646_57569018 | 3.33 |
Pakap |
paralemmin A kinase anchor protein |
2 |
0.99 |
chr8_57312048_57313282 | 3.33 |
Hand2os1 |
Hand2, opposite strand 1 |
1018 |
0.44 |
chr3_129216664_129219042 | 3.33 |
Pitx2 |
paired-like homeodomain transcription factor 2 |
3578 |
0.2 |
chr13_63170650_63171111 | 3.31 |
Aopep |
aminopeptidase O |
19376 |
0.12 |
chr16_25802324_25803670 | 3.30 |
Trp63 |
transformation related protein 63 |
1081 |
0.63 |
chr1_4495967_4497921 | 3.28 |
Sox17 |
SRY (sex determining region Y)-box 17 |
187 |
0.71 |
chr10_27615824_27617033 | 3.28 |
Lama2 |
laminin, alpha 2 |
368 |
0.8 |
chr13_73262153_73264451 | 3.28 |
Irx4 |
Iroquois homeobox 4 |
2805 |
0.22 |
chr11_35123294_35124903 | 3.28 |
Slit3 |
slit guidance ligand 3 |
2874 |
0.37 |
chr2_109693096_109694906 | 3.25 |
Bdnf |
brain derived neurotrophic factor |
408 |
0.85 |
chr8_57333046_57334560 | 3.25 |
Gm34030 |
predicted gene, 34030 |
584 |
0.59 |
chr19_47239858_47241187 | 3.25 |
Neurl1a |
neuralized E3 ubiquitin protein ligase 1A |
11611 |
0.11 |
chr16_14706735_14707615 | 3.25 |
Snai2 |
snail family zinc finger 2 |
1323 |
0.53 |
chr13_51410301_51411730 | 3.24 |
S1pr3 |
sphingosine-1-phosphate receptor 3 |
2376 |
0.29 |
chrX_106484603_106485985 | 3.22 |
Fndc3c1 |
fibronectin type III domain containing 3C1 |
20 |
0.98 |
chr11_100144835_100146198 | 3.22 |
Krt19 |
keratin 19 |
604 |
0.52 |
chr19_43385959_43387401 | 3.21 |
Hpse2 |
heparanase 2 |
1574 |
0.38 |
chr2_25577192_25580600 | 3.21 |
Ajm1 |
apical junction component 1 |
1001 |
0.25 |
chr12_56699459_56700760 | 3.21 |
Pax9 |
paired box 9 |
4380 |
0.18 |
chr2_168765766_168766653 | 3.20 |
Gm14261 |
predicted gene 14261 |
66 |
0.94 |
chr9_21846522_21847452 | 3.20 |
Dock6 |
dedicator of cytokinesis 6 |
5629 |
0.11 |
chr8_121082801_121085531 | 3.19 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr1_162219788_162220533 | 3.18 |
Dnm3os |
dynamin 3, opposite strand |
292 |
0.87 |
chr2_9880695_9881908 | 3.18 |
4930412O13Rik |
RIKEN cDNA 4930412O13 gene |
49 |
0.95 |
chr9_64017614_64019400 | 3.18 |
Smad6 |
SMAD family member 6 |
1520 |
0.33 |
chr17_47831995_47832317 | 3.18 |
Mdfi |
MyoD family inhibitor |
1013 |
0.42 |
chr6_52224853_52226609 | 3.17 |
Hoxa9 |
homeobox A9 |
458 |
0.51 |
chr8_87836615_87837599 | 3.17 |
Zfp423 |
zinc finger protein 423 |
32668 |
0.22 |
chr1_17727029_17728148 | 3.17 |
Gm16070 |
predicted gene 16070 |
58 |
0.89 |
chr3_146220721_146222114 | 3.17 |
Lpar3 |
lysophosphatidic acid receptor 3 |
454 |
0.82 |
chr4_44711553_44714511 | 3.16 |
Pax5 |
paired box 5 |
2545 |
0.22 |
chr6_51173127_51174365 | 3.15 |
Mir148a |
microRNA 148a |
96164 |
0.07 |
chr7_67648490_67649190 | 3.15 |
Ttc23 |
tetratricopeptide repeat domain 23 |
310 |
0.85 |
chr11_69399334_69402458 | 3.15 |
Kdm6bos |
KDM1 lysine (K)-specific demethylase 6B, opposite strand |
617 |
0.47 |
chr2_9874123_9875699 | 3.15 |
Gata3 |
GATA binding protein 3 |
488 |
0.68 |
chr11_99043636_99045890 | 3.14 |
Igfbp4 |
insulin-like growth factor binding protein 4 |
3 |
0.96 |
chr7_101820668_101822582 | 3.14 |
Phox2a |
paired-like homeobox 2a |
879 |
0.38 |
chr4_114410051_114411113 | 3.13 |
Trabd2b |
TraB domain containing 2B |
3858 |
0.36 |
chr7_3414859_3415977 | 3.12 |
Gm23450 |
predicted gene, 23450 |
352 |
0.74 |
chr8_89041062_89042862 | 3.11 |
Sall1 |
spalt like transcription factor 1 |
2200 |
0.35 |
chr4_139832357_139834219 | 3.11 |
Pax7 |
paired box 7 |
240 |
0.94 |
chr9_108479869_108480980 | 3.11 |
Lamb2 |
laminin, beta 2 |
543 |
0.5 |
chr12_9573836_9576858 | 3.10 |
Osr1 |
odd-skipped related transcription factor 1 |
906 |
0.56 |
chr13_40731940_40732438 | 3.09 |
Tfap2a |
transcription factor AP-2, alpha |
582 |
0.59 |
chr12_117153278_117156362 | 3.09 |
Gm10421 |
predicted gene 10421 |
3169 |
0.37 |
chr2_74682710_74683184 | 3.09 |
Gm28309 |
predicted gene 28309 |
499 |
0.38 |
chr5_119672433_119673011 | 3.09 |
Tbx3os1 |
T-box 3, opposite strand 1 |
1357 |
0.31 |
chr19_43888532_43890580 | 3.08 |
Dnmbp |
dynamin binding protein |
1135 |
0.42 |
chr4_133440098_133440707 | 3.08 |
Slc9a1 |
solute carrier family 9 (sodium/hydrogen exchanger), member 1 |
20430 |
0.12 |
chr4_57845019_57846302 | 3.07 |
Pakap |
paralemmin A kinase anchor protein |
412 |
0.86 |
chr4_121040824_121041109 | 3.07 |
Col9a2 |
collagen, type IX, alpha 2 |
1218 |
0.34 |
chr3_126996871_126998855 | 3.06 |
Ank2 |
ankyrin 2, brain |
575 |
0.63 |
chr13_71958597_71960663 | 3.06 |
Irx1 |
Iroquois homeobox 1 |
197 |
0.95 |
chr13_98501842_98503455 | 3.05 |
Gm10320 |
predicted pseudogene 10320 |
10647 |
0.13 |
chr3_86546255_86547878 | 3.05 |
Lrba |
LPS-responsive beige-like anchor |
311 |
0.85 |
chr2_35584984_35585507 | 3.05 |
Dab2ip |
disabled 2 interacting protein |
2405 |
0.28 |
chr1_90914789_90915631 | 3.04 |
Mlph |
melanophilin |
125 |
0.96 |
chr11_18873955_18876215 | 3.04 |
8430419K02Rik |
RIKEN cDNA 8430419K02 gene |
776 |
0.61 |
chr11_120706268_120707653 | 3.03 |
Aspscr1 |
alveolar soft part sarcoma chromosome region, candidate 1 (human) |
1698 |
0.13 |
chr5_119669544_119672401 | 3.03 |
Tbx3 |
T-box 3 |
46 |
0.85 |
chr8_70329553_70329704 | 3.03 |
Gdf1 |
growth differentiation factor 1 |
189 |
0.89 |
chr14_52310870_52313267 | 3.03 |
Sall2 |
spalt like transcription factor 2 |
4255 |
0.1 |
chr2_174283563_174287177 | 3.03 |
Gnas |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus |
12 |
0.53 |
chr5_33430330_33431900 | 3.02 |
Nkx1-1 |
NK1 homeobox 1 |
2861 |
0.23 |
chr3_10366508_10367397 | 3.02 |
Chmp4c |
charged multivesicular body protein 4C |
6 |
0.96 |
chr12_33966605_33968831 | 3.02 |
Twist1 |
twist basic helix-loop-helix transcription factor 1 |
10047 |
0.22 |
chr13_40732680_40733858 | 3.01 |
Tfap2a |
transcription factor AP-2, alpha |
509 |
0.65 |
chr4_141421681_141422558 | 3.00 |
Hspb7 |
heat shock protein family, member 7 (cardiovascular) |
1340 |
0.25 |
chr15_7814562_7815925 | 3.00 |
Gdnf |
glial cell line derived neurotrophic factor |
4397 |
0.24 |
chr15_84719703_84721036 | 2.99 |
Gm20556 |
predicted gene, 20556 |
103 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
5.9 | 23.5 | GO:0003166 | bundle of His development(GO:0003166) |
5.5 | 16.5 | GO:2001055 | positive regulation of mesenchymal cell apoptotic process(GO:2001055) |
5.2 | 20.8 | GO:0003253 | cardiac neural crest cell migration involved in outflow tract morphogenesis(GO:0003253) |
5.2 | 20.8 | GO:0007223 | Wnt signaling pathway, calcium modulating pathway(GO:0007223) |
4.7 | 14.2 | GO:0097168 | mesenchymal stem cell proliferation(GO:0097168) |
4.2 | 12.6 | GO:0002930 | trabecular meshwork development(GO:0002930) |
4.1 | 12.4 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
4.1 | 8.1 | GO:0072277 | glomerulus vasculature morphogenesis(GO:0072103) glomerular capillary formation(GO:0072104) metanephric glomerulus morphogenesis(GO:0072275) metanephric glomerulus vasculature morphogenesis(GO:0072276) metanephric glomerular capillary formation(GO:0072277) |
4.0 | 24.1 | GO:0097070 | ductus arteriosus closure(GO:0097070) |
4.0 | 12.0 | GO:0072199 | mesenchymal cell proliferation involved in ureter development(GO:0072198) regulation of mesenchymal cell proliferation involved in ureter development(GO:0072199) positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.7 | 7.4 | GO:0003278 | apoptotic process involved in heart morphogenesis(GO:0003278) |
3.5 | 7.1 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
3.5 | 10.6 | GO:0021524 | visceral motor neuron differentiation(GO:0021524) |
3.4 | 10.3 | GO:0003431 | growth plate cartilage chondrocyte development(GO:0003431) |
3.4 | 10.2 | GO:0097623 | potassium ion export across plasma membrane(GO:0097623) |
3.4 | 10.1 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
3.3 | 13.1 | GO:0021557 | oculomotor nerve development(GO:0021557) |
2.9 | 8.7 | GO:0060594 | mammary gland specification(GO:0060594) |
2.9 | 8.7 | GO:1902809 | regulation of skeletal muscle fiber differentiation(GO:1902809) |
2.9 | 8.7 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
2.9 | 5.7 | GO:0003433 | chondrocyte development involved in endochondral bone morphogenesis(GO:0003433) |
2.7 | 8.2 | GO:1900825 | regulation of membrane depolarization during cardiac muscle cell action potential(GO:1900825) |
2.7 | 29.8 | GO:0060272 | embryonic skeletal joint morphogenesis(GO:0060272) |
2.7 | 8.1 | GO:0003176 | aortic valve development(GO:0003176) aortic valve morphogenesis(GO:0003180) |
2.5 | 7.6 | GO:0060513 | prostatic bud formation(GO:0060513) |
2.5 | 9.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.4 | 4.9 | GO:0061146 | Peyer's patch morphogenesis(GO:0061146) |
2.4 | 7.3 | GO:0072092 | ureteric bud invasion(GO:0072092) |
2.4 | 2.4 | GO:0061205 | paramesonephric duct development(GO:0061205) |
2.4 | 7.1 | GO:0046552 | eye photoreceptor cell fate commitment(GO:0042706) photoreceptor cell fate commitment(GO:0046552) |
2.3 | 2.3 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
2.3 | 6.8 | GO:0021570 | rhombomere 4 development(GO:0021570) |
2.2 | 11.2 | GO:0021563 | glossopharyngeal nerve development(GO:0021563) |
2.2 | 4.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
2.2 | 6.6 | GO:2000054 | negative regulation of Wnt signaling pathway involved in dorsal/ventral axis specification(GO:2000054) |
2.1 | 4.3 | GO:0048880 | sensory system development(GO:0048880) |
2.1 | 4.2 | GO:0021569 | rhombomere 3 development(GO:0021569) |
2.1 | 6.4 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
2.1 | 6.2 | GO:0060129 | corticotropin hormone secreting cell differentiation(GO:0060128) thyroid-stimulating hormone-secreting cell differentiation(GO:0060129) |
2.0 | 2.0 | GO:0070384 | Harderian gland development(GO:0070384) |
2.0 | 2.0 | GO:0060842 | arterial endothelial cell differentiation(GO:0060842) |
1.9 | 5.6 | GO:2000599 | regulation of cyclin catabolic process(GO:2000598) negative regulation of cyclin catabolic process(GO:2000599) |
1.9 | 3.7 | GO:0060687 | regulation of branching involved in prostate gland morphogenesis(GO:0060687) |
1.9 | 3.7 | GO:0035799 | ureter maturation(GO:0035799) |
1.9 | 5.6 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
1.8 | 5.5 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
1.8 | 5.5 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
1.8 | 9.1 | GO:0003256 | regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation(GO:0003256) |
1.8 | 1.8 | GO:0060839 | endothelial cell fate commitment(GO:0060839) |
1.8 | 1.8 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.8 | 3.6 | GO:0003284 | septum primum development(GO:0003284) atrial septum primum morphogenesis(GO:0003289) |
1.8 | 1.8 | GO:0072050 | S-shaped body morphogenesis(GO:0072050) |
1.8 | 15.9 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
1.7 | 19.2 | GO:0048672 | positive regulation of collateral sprouting(GO:0048672) |
1.7 | 3.4 | GO:0010482 | epidermal cell division(GO:0010481) regulation of epidermal cell division(GO:0010482) |
1.7 | 12.0 | GO:2000288 | positive regulation of myoblast proliferation(GO:2000288) |
1.7 | 3.4 | GO:0061314 | Notch signaling involved in heart development(GO:0061314) |
1.7 | 15.4 | GO:0060394 | negative regulation of pathway-restricted SMAD protein phosphorylation(GO:0060394) |
1.7 | 32.0 | GO:0009954 | proximal/distal pattern formation(GO:0009954) |
1.7 | 5.0 | GO:0034653 | diterpenoid catabolic process(GO:0016103) retinoic acid catabolic process(GO:0034653) |
1.7 | 6.7 | GO:0060750 | epithelial cell proliferation involved in mammary gland duct elongation(GO:0060750) |
1.7 | 3.3 | GO:0009786 | regulation of asymmetric cell division(GO:0009786) |
1.7 | 3.3 | GO:2000977 | regulation of forebrain neuron differentiation(GO:2000977) |
1.7 | 3.3 | GO:0072107 | regulation of ureteric bud formation(GO:0072106) positive regulation of ureteric bud formation(GO:0072107) |
1.7 | 1.7 | GO:0016539 | intein-mediated protein splicing(GO:0016539) protein splicing(GO:0030908) |
1.6 | 3.3 | GO:0060174 | limb bud formation(GO:0060174) |
1.6 | 9.8 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.6 | 4.9 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
1.6 | 4.9 | GO:2000860 | positive regulation of mineralocorticoid secretion(GO:2000857) positive regulation of aldosterone secretion(GO:2000860) |
1.6 | 1.6 | GO:0042249 | establishment of planar polarity of embryonic epithelium(GO:0042249) |
1.6 | 4.8 | GO:0060591 | chondroblast differentiation(GO:0060591) |
1.6 | 6.3 | GO:0036072 | intramembranous ossification(GO:0001957) direct ossification(GO:0036072) |
1.6 | 3.1 | GO:0044333 | Wnt signaling pathway involved in digestive tract morphogenesis(GO:0044333) |
1.5 | 9.3 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
1.5 | 6.2 | GO:1901166 | neural crest cell migration involved in autonomic nervous system development(GO:1901166) |
1.5 | 7.6 | GO:0060501 | positive regulation of epithelial cell proliferation involved in lung morphogenesis(GO:0060501) |
1.5 | 1.5 | GO:0048320 | axial mesoderm formation(GO:0048320) |
1.5 | 1.5 | GO:0021855 | hypothalamus cell migration(GO:0021855) |
1.5 | 4.6 | GO:0035995 | detection of muscle stretch(GO:0035995) |
1.5 | 7.6 | GO:0033564 | anterior/posterior axon guidance(GO:0033564) |
1.5 | 7.5 | GO:1904948 | midbrain dopaminergic neuron differentiation(GO:1904948) |
1.5 | 3.0 | GO:0060486 | Clara cell differentiation(GO:0060486) |
1.5 | 5.8 | GO:0098735 | positive regulation of the force of heart contraction(GO:0098735) |
1.4 | 2.9 | GO:0001757 | somite specification(GO:0001757) |
1.4 | 1.4 | GO:0060435 | bronchiole development(GO:0060435) |
1.4 | 2.8 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
1.4 | 2.8 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
1.4 | 1.4 | GO:0021571 | rhombomere 5 development(GO:0021571) |
1.4 | 5.5 | GO:0071651 | positive regulation of chemokine (C-C motif) ligand 5 production(GO:0071651) |
1.4 | 6.9 | GO:0003184 | pulmonary valve development(GO:0003177) pulmonary valve morphogenesis(GO:0003184) |
1.4 | 4.1 | GO:1903984 | positive regulation of TRAIL-activated apoptotic signaling pathway(GO:1903984) |
1.4 | 2.7 | GO:0072108 | positive regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0072108) |
1.4 | 1.4 | GO:0061304 | retinal blood vessel morphogenesis(GO:0061304) |
1.4 | 5.4 | GO:0010424 | DNA methylation on cytosine within a CG sequence(GO:0010424) DNA methylation on cytosine(GO:0032776) |
1.4 | 2.7 | GO:0003264 | cardioblast proliferation(GO:0003263) regulation of cardioblast proliferation(GO:0003264) regulation of secondary heart field cardioblast proliferation(GO:0003266) |
1.3 | 4.0 | GO:2000382 | positive regulation of mesoderm development(GO:2000382) |
1.3 | 4.0 | GO:0003347 | epicardial cell to mesenchymal cell transition(GO:0003347) |
1.3 | 2.7 | GO:0007403 | glial cell fate determination(GO:0007403) |
1.3 | 5.2 | GO:0030035 | microspike assembly(GO:0030035) |
1.3 | 3.9 | GO:1903847 | regulation of aorta morphogenesis(GO:1903847) positive regulation of aorta morphogenesis(GO:1903849) |
1.3 | 5.2 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
1.3 | 2.5 | GO:0046532 | regulation of photoreceptor cell differentiation(GO:0046532) |
1.3 | 2.5 | GO:0021520 | spinal cord motor neuron cell fate specification(GO:0021520) |
1.2 | 5.0 | GO:1902894 | negative regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902894) |
1.2 | 8.7 | GO:0048664 | neuron fate determination(GO:0048664) |
1.2 | 2.5 | GO:0090027 | negative regulation of monocyte chemotaxis(GO:0090027) |
1.2 | 2.5 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
1.2 | 2.5 | GO:0014028 | notochord formation(GO:0014028) |
1.2 | 8.5 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
1.2 | 12.1 | GO:0003417 | growth plate cartilage development(GO:0003417) |
1.2 | 6.0 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
1.2 | 6.0 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
1.2 | 2.4 | GO:0061144 | alveolar secondary septum development(GO:0061144) |
1.2 | 2.4 | GO:0033686 | positive regulation of luteinizing hormone secretion(GO:0033686) |
1.2 | 3.5 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
1.2 | 3.5 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
1.2 | 2.3 | GO:0003273 | cell migration involved in endocardial cushion formation(GO:0003273) |
1.2 | 1.2 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
1.2 | 3.5 | GO:0071673 | positive regulation of smooth muscle cell chemotaxis(GO:0071673) |
1.2 | 1.2 | GO:0002339 | B cell selection(GO:0002339) |
1.1 | 3.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
1.1 | 5.7 | GO:0038031 | non-canonical Wnt signaling pathway via JNK cascade(GO:0038031) |
1.1 | 3.4 | GO:0072307 | metanephric nephron tubule epithelial cell differentiation(GO:0072257) regulation of metanephric nephron tubule epithelial cell differentiation(GO:0072307) |
1.1 | 1.1 | GO:0007183 | SMAD protein complex assembly(GO:0007183) |
1.1 | 5.7 | GO:0010626 | negative regulation of Schwann cell proliferation(GO:0010626) |
1.1 | 5.7 | GO:1904424 | regulation of GTP binding(GO:1904424) |
1.1 | 2.3 | GO:0072053 | renal inner medulla development(GO:0072053) |
1.1 | 1.1 | GO:0061209 | cell proliferation involved in mesonephros development(GO:0061209) |
1.1 | 2.2 | GO:0072174 | metanephric tubule formation(GO:0072174) |
1.1 | 1.1 | GO:0006842 | tricarboxylic acid transport(GO:0006842) citrate transport(GO:0015746) |
1.1 | 1.1 | GO:0003148 | outflow tract septum morphogenesis(GO:0003148) |
1.1 | 2.2 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
1.1 | 1.1 | GO:0035993 | deltoid tuberosity development(GO:0035993) |
1.1 | 7.7 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.1 | 2.2 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) |
1.1 | 3.3 | GO:1902498 | regulation of protein autoubiquitination(GO:1902498) |
1.1 | 2.2 | GO:1904261 | regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904259) positive regulation of basement membrane assembly involved in embryonic body morphogenesis(GO:1904261) basement membrane assembly involved in embryonic body morphogenesis(GO:2001197) |
1.1 | 62.6 | GO:0048704 | embryonic skeletal system morphogenesis(GO:0048704) |
1.1 | 2.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.1 | 5.3 | GO:0097500 | receptor localization to nonmotile primary cilium(GO:0097500) |
1.1 | 1.1 | GO:0003164 | His-Purkinje system development(GO:0003164) |
1.1 | 7.4 | GO:0060040 | retinal bipolar neuron differentiation(GO:0060040) |
1.1 | 3.2 | GO:0032348 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
1.1 | 3.2 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
1.1 | 1.1 | GO:0061055 | myotome development(GO:0061055) |
1.0 | 3.1 | GO:0015889 | cobalamin transport(GO:0015889) |
1.0 | 7.2 | GO:0048251 | elastic fiber assembly(GO:0048251) |
1.0 | 2.1 | GO:0021555 | midbrain-hindbrain boundary morphogenesis(GO:0021555) |
1.0 | 6.2 | GO:0035878 | nail development(GO:0035878) |
1.0 | 2.1 | GO:0098915 | membrane repolarization during ventricular cardiac muscle cell action potential(GO:0098915) |
1.0 | 2.0 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.0 | 1.0 | GO:0060585 | regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
1.0 | 1.0 | GO:0003199 | endocardial cushion to mesenchymal transition involved in heart valve formation(GO:0003199) |
1.0 | 4.1 | GO:0048368 | lateral mesoderm development(GO:0048368) |
1.0 | 5.0 | GO:0051121 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) |
1.0 | 3.0 | GO:0045218 | zonula adherens maintenance(GO:0045218) |
1.0 | 7.0 | GO:0045198 | establishment of epithelial cell apical/basal polarity(GO:0045198) |
1.0 | 1.0 | GO:0048769 | sarcomerogenesis(GO:0048769) |
1.0 | 1.0 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
1.0 | 2.0 | GO:0003219 | cardiac right ventricle formation(GO:0003219) |
1.0 | 8.8 | GO:0021521 | ventral spinal cord interneuron specification(GO:0021521) cell fate specification involved in pattern specification(GO:0060573) |
1.0 | 2.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
1.0 | 1.0 | GO:0060601 | lateral sprouting from an epithelium(GO:0060601) |
1.0 | 8.8 | GO:0038065 | collagen-activated signaling pathway(GO:0038065) |
1.0 | 2.9 | GO:1903423 | positive regulation of synaptic vesicle recycling(GO:1903423) |
1.0 | 3.9 | GO:0003416 | endochondral bone growth(GO:0003416) |
1.0 | 2.9 | GO:0070100 | negative regulation of chemokine-mediated signaling pathway(GO:0070100) |
1.0 | 2.9 | GO:0007525 | somatic muscle development(GO:0007525) |
1.0 | 2.9 | GO:0009838 | abscission(GO:0009838) |
1.0 | 4.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.0 | 2.9 | GO:0060684 | epithelial-mesenchymal cell signaling(GO:0060684) |
1.0 | 1.0 | GO:0072205 | metanephric collecting duct development(GO:0072205) |
1.0 | 1.9 | GO:0035992 | tendon cell differentiation(GO:0035990) tendon formation(GO:0035992) |
1.0 | 2.9 | GO:0032474 | otolith morphogenesis(GO:0032474) |
1.0 | 4.8 | GO:0072675 | osteoclast fusion(GO:0072675) |
0.9 | 2.8 | GO:0050968 | detection of chemical stimulus involved in sensory perception of pain(GO:0050968) |
0.9 | 2.8 | GO:0097029 | mature conventional dendritic cell differentiation(GO:0097029) |
0.9 | 3.8 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.9 | 3.7 | GO:0014826 | vein smooth muscle contraction(GO:0014826) |
0.9 | 1.9 | GO:0018992 | germ-line sex determination(GO:0018992) |
0.9 | 5.6 | GO:0032331 | negative regulation of chondrocyte differentiation(GO:0032331) |
0.9 | 2.8 | GO:0021773 | striatal medium spiny neuron differentiation(GO:0021773) |
0.9 | 1.8 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
0.9 | 3.6 | GO:1904995 | negative regulation of leukocyte adhesion to vascular endothelial cell(GO:1904995) |
0.9 | 0.9 | GO:0060579 | ventral spinal cord interneuron fate commitment(GO:0060579) cell fate commitment involved in pattern specification(GO:0060581) |
0.9 | 2.7 | GO:0030421 | defecation(GO:0030421) |
0.9 | 3.6 | GO:0033600 | negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.9 | 2.7 | GO:0014891 | striated muscle atrophy(GO:0014891) |
0.9 | 2.7 | GO:0035262 | gonad morphogenesis(GO:0035262) |
0.9 | 2.7 | GO:1902564 | negative regulation of neutrophil activation(GO:1902564) |
0.9 | 2.7 | GO:0071415 | cellular response to caffeine(GO:0071313) cellular response to purine-containing compound(GO:0071415) |
0.9 | 0.9 | GO:0061004 | pattern specification involved in kidney development(GO:0061004) renal system pattern specification(GO:0072048) |
0.9 | 2.6 | GO:0071898 | regulation of estrogen receptor binding(GO:0071898) negative regulation of estrogen receptor binding(GO:0071899) |
0.9 | 3.5 | GO:0048852 | diencephalon morphogenesis(GO:0048852) |
0.9 | 3.5 | GO:0048549 | positive regulation of pinocytosis(GO:0048549) |
0.9 | 0.9 | GO:0033278 | cell proliferation in midbrain(GO:0033278) |
0.9 | 1.7 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) |
0.9 | 4.3 | GO:0060068 | vagina development(GO:0060068) |
0.8 | 0.8 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.8 | 2.5 | GO:0033861 | negative regulation of NAD(P)H oxidase activity(GO:0033861) |
0.8 | 2.5 | GO:1904059 | regulation of locomotor rhythm(GO:1904059) |
0.8 | 5.0 | GO:0070314 | G1 to G0 transition(GO:0070314) |
0.8 | 0.8 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
0.8 | 0.8 | GO:0050923 | regulation of negative chemotaxis(GO:0050923) |
0.8 | 1.7 | GO:2000645 | negative regulation of receptor catabolic process(GO:2000645) |
0.8 | 1.6 | GO:0032439 | endosome localization(GO:0032439) |
0.8 | 4.1 | GO:0061591 | calcium activated phospholipid scrambling(GO:0061588) calcium activated phosphatidylcholine scrambling(GO:0061590) calcium activated galactosylceramide scrambling(GO:0061591) |
0.8 | 4.1 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.8 | 6.5 | GO:0032332 | positive regulation of chondrocyte differentiation(GO:0032332) |
0.8 | 1.6 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.8 | 1.6 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.8 | 4.0 | GO:1903012 | positive regulation of bone development(GO:1903012) |
0.8 | 0.8 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
0.8 | 1.6 | GO:0051594 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
0.8 | 0.8 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.8 | 1.5 | GO:0048625 | myoblast fate commitment(GO:0048625) |
0.8 | 2.3 | GO:0072243 | metanephric nephron epithelium development(GO:0072243) |
0.8 | 2.3 | GO:0071679 | commissural neuron axon guidance(GO:0071679) |
0.7 | 1.5 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
0.7 | 2.2 | GO:1900620 | acetylcholine biosynthetic process(GO:0008292) acetate ester biosynthetic process(GO:1900620) |
0.7 | 2.2 | GO:0060283 | negative regulation of oocyte development(GO:0060283) |
0.7 | 2.2 | GO:1903232 | melanosome assembly(GO:1903232) |
0.7 | 4.4 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.7 | 2.9 | GO:0010455 | positive regulation of cell fate commitment(GO:0010455) |
0.7 | 2.9 | GO:0050927 | positive regulation of positive chemotaxis(GO:0050927) |
0.7 | 2.2 | GO:0046103 | inosine biosynthetic process(GO:0046103) |
0.7 | 3.6 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.7 | 0.7 | GO:0060437 | lung growth(GO:0060437) |
0.7 | 1.4 | GO:0014016 | neuroblast differentiation(GO:0014016) |
0.7 | 1.4 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.7 | 6.4 | GO:0021854 | hypothalamus development(GO:0021854) |
0.7 | 0.7 | GO:1903935 | response to sodium arsenite(GO:1903935) |
0.7 | 13.4 | GO:0016339 | calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0016339) |
0.7 | 2.1 | GO:0060290 | transdifferentiation(GO:0060290) |
0.7 | 0.7 | GO:0060923 | cardiac muscle cell fate commitment(GO:0060923) |
0.7 | 1.4 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.7 | 2.1 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
0.7 | 0.7 | GO:0060221 | retinal rod cell differentiation(GO:0060221) |
0.7 | 0.7 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
0.7 | 1.4 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.7 | 4.8 | GO:0040037 | negative regulation of fibroblast growth factor receptor signaling pathway(GO:0040037) |
0.7 | 7.5 | GO:0031290 | retinal ganglion cell axon guidance(GO:0031290) |
0.7 | 2.7 | GO:0060316 | positive regulation of ryanodine-sensitive calcium-release channel activity(GO:0060316) |
0.7 | 0.7 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
0.7 | 12.0 | GO:0048706 | embryonic skeletal system development(GO:0048706) |
0.7 | 1.3 | GO:0061428 | negative regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061428) |
0.7 | 5.3 | GO:0051764 | actin crosslink formation(GO:0051764) |
0.7 | 2.0 | GO:1904378 | maintenance of unfolded protein(GO:0036506) maintenance of unfolded protein involved in ERAD pathway(GO:1904378) |
0.7 | 0.7 | GO:2001027 | negative regulation of endothelial cell chemotaxis(GO:2001027) |
0.6 | 1.9 | GO:0060160 | negative regulation of dopamine receptor signaling pathway(GO:0060160) |
0.6 | 4.5 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.6 | 0.6 | GO:0051142 | regulation of NK T cell proliferation(GO:0051140) positive regulation of NK T cell proliferation(GO:0051142) |
0.6 | 1.9 | GO:0071169 | establishment of protein localization to chromatin(GO:0071169) |
0.6 | 1.9 | GO:0051136 | regulation of NK T cell differentiation(GO:0051136) positive regulation of NK T cell differentiation(GO:0051138) |
0.6 | 0.6 | GO:0046684 | response to pyrethroid(GO:0046684) |
0.6 | 5.1 | GO:0003334 | keratinocyte development(GO:0003334) |
0.6 | 3.2 | GO:0035469 | determination of pancreatic left/right asymmetry(GO:0035469) |
0.6 | 1.3 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.6 | 1.9 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.6 | 0.6 | GO:0072207 | metanephric epithelium development(GO:0072207) |
0.6 | 1.9 | GO:0016080 | synaptic vesicle targeting(GO:0016080) |
0.6 | 3.1 | GO:0080154 | regulation of fertilization(GO:0080154) |
0.6 | 2.5 | GO:1903054 | negative regulation of extracellular matrix organization(GO:1903054) |
0.6 | 1.2 | GO:0021869 | forebrain ventricular zone progenitor cell division(GO:0021869) |
0.6 | 0.6 | GO:0090500 | endocardial cushion to mesenchymal transition(GO:0090500) |
0.6 | 1.2 | GO:0014873 | response to muscle activity involved in regulation of muscle adaptation(GO:0014873) |
0.6 | 1.2 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.6 | 0.6 | GO:0072194 | kidney smooth muscle tissue development(GO:0072194) |
0.6 | 0.6 | GO:0090175 | regulation of establishment of planar polarity(GO:0090175) |
0.6 | 0.6 | GO:0086013 | membrane repolarization during cardiac muscle cell action potential(GO:0086013) |
0.6 | 1.8 | GO:0033504 | floor plate development(GO:0033504) |
0.6 | 3.6 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.6 | 1.2 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) |
0.6 | 1.2 | GO:0051388 | positive regulation of neurotrophin TRK receptor signaling pathway(GO:0051388) |
0.6 | 1.8 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) |
0.6 | 2.4 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
0.6 | 0.6 | GO:0014900 | regulation of muscle hyperplasia(GO:0014738) muscle hyperplasia(GO:0014900) |
0.6 | 6.4 | GO:0046322 | negative regulation of fatty acid oxidation(GO:0046322) |
0.6 | 1.8 | GO:0045415 | negative regulation of interleukin-8 biosynthetic process(GO:0045415) |
0.6 | 1.7 | GO:0060331 | negative regulation of response to interferon-gamma(GO:0060331) negative regulation of interferon-gamma-mediated signaling pathway(GO:0060336) |
0.6 | 1.2 | GO:0071798 | response to prostaglandin D(GO:0071798) cellular response to prostaglandin D stimulus(GO:0071799) |
0.6 | 0.6 | GO:0001945 | lymph vessel development(GO:0001945) |
0.6 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.6 | 0.6 | GO:0010535 | positive regulation of activation of JAK2 kinase activity(GO:0010535) |
0.6 | 0.6 | GO:0014724 | regulation of twitch skeletal muscle contraction(GO:0014724) |
0.6 | 3.4 | GO:0060347 | heart trabecula formation(GO:0060347) |
0.6 | 1.7 | GO:0015803 | branched-chain amino acid transport(GO:0015803) leucine transport(GO:0015820) |
0.6 | 1.1 | GO:0061037 | negative regulation of cartilage development(GO:0061037) |
0.6 | 1.1 | GO:0072319 | clathrin coat disassembly(GO:0072318) vesicle uncoating(GO:0072319) |
0.6 | 1.1 | GO:0021559 | trigeminal nerve development(GO:0021559) |
0.6 | 0.6 | GO:0035989 | tendon development(GO:0035989) |
0.6 | 0.6 | GO:0097374 | sensory neuron axon guidance(GO:0097374) |
0.6 | 1.1 | GO:0051466 | positive regulation of corticotropin-releasing hormone secretion(GO:0051466) |
0.6 | 0.6 | GO:0050957 | equilibrioception(GO:0050957) |
0.5 | 0.5 | GO:0061525 | hindgut development(GO:0061525) |
0.5 | 0.5 | GO:0035622 | intrahepatic bile duct development(GO:0035622) |
0.5 | 2.2 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.5 | 3.3 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.5 | 1.1 | GO:0048743 | positive regulation of skeletal muscle fiber development(GO:0048743) |
0.5 | 5.9 | GO:0071545 | inositol phosphate catabolic process(GO:0071545) |
0.5 | 1.6 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
0.5 | 0.5 | GO:0042360 | vitamin E metabolic process(GO:0042360) |
0.5 | 1.6 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
0.5 | 1.6 | GO:0015744 | succinate transport(GO:0015744) |
0.5 | 0.5 | GO:0060300 | regulation of cytokine activity(GO:0060300) |
0.5 | 1.1 | GO:0097155 | fasciculation of sensory neuron axon(GO:0097155) |
0.5 | 3.2 | GO:0021936 | regulation of cerebellar granule cell precursor proliferation(GO:0021936) |
0.5 | 2.6 | GO:0050748 | negative regulation of lipoprotein metabolic process(GO:0050748) |
0.5 | 3.7 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
0.5 | 4.2 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.5 | 0.5 | GO:0061074 | regulation of neural retina development(GO:0061074) |
0.5 | 1.6 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.5 | 1.6 | GO:2000020 | positive regulation of male gonad development(GO:2000020) |
0.5 | 1.6 | GO:1902896 | terminal web assembly(GO:1902896) |
0.5 | 3.6 | GO:0008343 | adult feeding behavior(GO:0008343) |
0.5 | 3.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
0.5 | 1.0 | GO:0010182 | carbohydrate mediated signaling(GO:0009756) hexose mediated signaling(GO:0009757) sugar mediated signaling pathway(GO:0010182) glucose mediated signaling pathway(GO:0010255) |
0.5 | 1.0 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
0.5 | 0.5 | GO:0072674 | multinuclear osteoclast differentiation(GO:0072674) |
0.5 | 1.5 | GO:0090214 | spongiotrophoblast layer developmental growth(GO:0090214) |
0.5 | 4.0 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.5 | 1.5 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.5 | 1.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.5 | 1.5 | GO:0002121 | inter-male aggressive behavior(GO:0002121) |
0.5 | 0.5 | GO:0060423 | foregut regionalization(GO:0060423) lung field specification(GO:0060424) lung induction(GO:0060492) |
0.5 | 4.0 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.5 | 3.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.5 | 1.5 | GO:0051045 | negative regulation of membrane protein ectodomain proteolysis(GO:0051045) |
0.5 | 10.0 | GO:0060325 | face morphogenesis(GO:0060325) |
0.5 | 1.0 | GO:2000721 | positive regulation of transcription from RNA polymerase II promoter involved in smooth muscle cell differentiation(GO:2000721) |
0.5 | 6.0 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
0.5 | 1.5 | GO:0060037 | pharyngeal system development(GO:0060037) |
0.5 | 3.0 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
0.5 | 2.5 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
0.5 | 0.5 | GO:0033088 | negative regulation of immature T cell proliferation in thymus(GO:0033088) |
0.5 | 1.0 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
0.5 | 2.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.5 | 1.5 | GO:0045618 | positive regulation of keratinocyte differentiation(GO:0045618) |
0.5 | 2.9 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
0.5 | 0.5 | GO:2000980 | regulation of auditory receptor cell differentiation(GO:0045607) regulation of mechanoreceptor differentiation(GO:0045631) regulation of inner ear receptor cell differentiation(GO:2000980) |
0.5 | 1.9 | GO:0070141 | response to UV-A(GO:0070141) |
0.5 | 0.5 | GO:0060638 | mesenchymal-epithelial cell signaling(GO:0060638) |
0.5 | 1.9 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.5 | 1.4 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.5 | 1.4 | GO:0001893 | maternal placenta development(GO:0001893) |
0.5 | 1.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.5 | 1.0 | GO:0008065 | establishment of blood-nerve barrier(GO:0008065) |
0.5 | 1.9 | GO:0042637 | catagen(GO:0042637) |
0.5 | 1.0 | GO:0060510 | Type II pneumocyte differentiation(GO:0060510) |
0.5 | 1.4 | GO:1903011 | negative regulation of bone development(GO:1903011) |
0.5 | 1.9 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.5 | 0.9 | GO:0060405 | regulation of penile erection(GO:0060405) positive regulation of penile erection(GO:0060406) |
0.5 | 0.5 | GO:0003149 | membranous septum morphogenesis(GO:0003149) mesenchymal stem cell differentiation(GO:0072497) |
0.5 | 1.4 | GO:0002125 | maternal aggressive behavior(GO:0002125) |
0.5 | 1.9 | GO:0090403 | oxidative stress-induced premature senescence(GO:0090403) |
0.5 | 0.9 | GO:0010046 | response to mycotoxin(GO:0010046) |
0.5 | 0.5 | GO:0032344 | regulation of aldosterone metabolic process(GO:0032344) |
0.5 | 0.9 | GO:0086046 | membrane depolarization during SA node cell action potential(GO:0086046) |
0.5 | 1.4 | GO:2000686 | regulation of rubidium ion transmembrane transporter activity(GO:2000686) |
0.5 | 1.4 | GO:0006667 | sphinganine metabolic process(GO:0006667) |
0.5 | 0.9 | GO:0034651 | cortisol biosynthetic process(GO:0034651) |
0.5 | 1.4 | GO:0010982 | regulation of high-density lipoprotein particle clearance(GO:0010982) |
0.5 | 1.4 | GO:0071692 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.5 | 1.4 | GO:1901386 | negative regulation of voltage-gated calcium channel activity(GO:1901386) |
0.5 | 1.4 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.5 | 0.5 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
0.5 | 0.9 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
0.5 | 1.8 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.5 | 1.4 | GO:0010172 | embryonic body morphogenesis(GO:0010172) |
0.5 | 0.5 | GO:0050883 | musculoskeletal movement, spinal reflex action(GO:0050883) |
0.5 | 1.8 | GO:0048050 | post-embryonic eye morphogenesis(GO:0048050) |
0.5 | 1.4 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
0.4 | 0.4 | GO:0021648 | vestibulocochlear nerve morphogenesis(GO:0021648) |
0.4 | 0.4 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.4 | 2.2 | GO:0006477 | protein sulfation(GO:0006477) |
0.4 | 1.3 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.4 | 0.4 | GO:0032513 | negative regulation of protein phosphatase type 2B activity(GO:0032513) |
0.4 | 0.4 | GO:1901420 | negative regulation of response to alcohol(GO:1901420) |
0.4 | 0.4 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
0.4 | 1.3 | GO:0031033 | myosin filament organization(GO:0031033) |
0.4 | 3.1 | GO:0061158 | 3'-UTR-mediated mRNA destabilization(GO:0061158) |
0.4 | 1.3 | GO:0014816 | skeletal muscle satellite cell differentiation(GO:0014816) |
0.4 | 0.4 | GO:1901727 | positive regulation of histone deacetylase activity(GO:1901727) |
0.4 | 1.7 | GO:0060708 | spongiotrophoblast differentiation(GO:0060708) |
0.4 | 1.7 | GO:0043435 | response to corticotropin-releasing hormone(GO:0043435) cellular response to corticotropin-releasing hormone stimulus(GO:0071376) |
0.4 | 1.7 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
0.4 | 0.8 | GO:0071332 | cellular response to fructose stimulus(GO:0071332) |
0.4 | 1.7 | GO:0021513 | spinal cord dorsal/ventral patterning(GO:0021513) |
0.4 | 1.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
0.4 | 1.3 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
0.4 | 1.2 | GO:0018242 | protein O-linked glycosylation via serine(GO:0018242) |
0.4 | 1.2 | GO:0061042 | vascular wound healing(GO:0061042) |
0.4 | 1.2 | GO:0033629 | negative regulation of cell adhesion mediated by integrin(GO:0033629) |
0.4 | 1.2 | GO:0033499 | galactose catabolic process via UDP-galactose(GO:0033499) glycolytic process from galactose(GO:0061623) |
0.4 | 0.8 | GO:0030916 | otic vesicle formation(GO:0030916) |
0.4 | 4.0 | GO:0060670 | branching involved in labyrinthine layer morphogenesis(GO:0060670) |
0.4 | 1.2 | GO:0072051 | juxtaglomerular apparatus development(GO:0072051) |
0.4 | 2.8 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
0.4 | 0.4 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
0.4 | 1.2 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.4 | 1.6 | GO:0010288 | response to lead ion(GO:0010288) |
0.4 | 0.8 | GO:0003383 | apical constriction(GO:0003383) |
0.4 | 2.0 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.4 | 0.8 | GO:0036301 | macrophage colony-stimulating factor production(GO:0036301) granulocyte colony-stimulating factor production(GO:0071611) regulation of granulocyte colony-stimulating factor production(GO:0071655) regulation of macrophage colony-stimulating factor production(GO:1901256) |
0.4 | 0.4 | GO:0016115 | terpenoid catabolic process(GO:0016115) |
0.4 | 0.8 | GO:0090179 | planar cell polarity pathway involved in neural tube closure(GO:0090179) |
0.4 | 1.2 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
0.4 | 0.8 | GO:1902415 | regulation of mRNA binding(GO:1902415) regulation of RNA binding(GO:1905214) |
0.4 | 4.7 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
0.4 | 0.4 | GO:0014042 | positive regulation of neuron maturation(GO:0014042) |
0.4 | 0.8 | GO:0007181 | transforming growth factor beta receptor complex assembly(GO:0007181) |
0.4 | 1.2 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
0.4 | 4.7 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.4 | 4.3 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 1.2 | GO:0010446 | response to alkaline pH(GO:0010446) |
0.4 | 0.8 | GO:0061366 | behavioral response to chemical pain(GO:0061366) behavioral response to formalin induced pain(GO:0061368) |
0.4 | 1.2 | GO:0097503 | sialylation(GO:0097503) |
0.4 | 1.1 | GO:0036438 | maintenance of lens transparency(GO:0036438) |
0.4 | 1.5 | GO:1903361 | protein localization to basolateral plasma membrane(GO:1903361) |
0.4 | 1.1 | GO:0042376 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.4 | 1.1 | GO:0048505 | regulation of timing of cell differentiation(GO:0048505) |
0.4 | 0.4 | GO:0035137 | hindlimb morphogenesis(GO:0035137) |
0.4 | 1.5 | GO:0007196 | adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway(GO:0007196) |
0.4 | 0.4 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.4 | 1.1 | GO:0010715 | regulation of extracellular matrix disassembly(GO:0010715) |
0.4 | 2.6 | GO:0010719 | negative regulation of epithelial to mesenchymal transition(GO:0010719) |
0.4 | 1.9 | GO:0010739 | positive regulation of protein kinase A signaling(GO:0010739) |
0.4 | 1.5 | GO:0060856 | establishment of blood-brain barrier(GO:0060856) |
0.4 | 0.4 | GO:1901668 | regulation of superoxide dismutase activity(GO:1901668) |
0.4 | 0.7 | GO:0051410 | detoxification of nitrogen compound(GO:0051410) cellular detoxification of nitrogen compound(GO:0070458) |
0.4 | 2.2 | GO:0018158 | protein oxidation(GO:0018158) |
0.4 | 3.6 | GO:0030513 | positive regulation of BMP signaling pathway(GO:0030513) |
0.4 | 0.4 | GO:0048696 | regulation of collateral sprouting in absence of injury(GO:0048696) |
0.4 | 0.7 | GO:0007379 | segment specification(GO:0007379) |
0.4 | 0.4 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.4 | 1.4 | GO:0099623 | regulation of cardiac muscle cell membrane repolarization(GO:0099623) |
0.4 | 0.7 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.4 | 3.2 | GO:0001709 | cell fate determination(GO:0001709) |
0.4 | 2.1 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.4 | 1.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
0.4 | 1.1 | GO:0042414 | epinephrine metabolic process(GO:0042414) |
0.3 | 3.1 | GO:0006590 | thyroid hormone generation(GO:0006590) |
0.3 | 0.7 | GO:0061743 | motor learning(GO:0061743) |
0.3 | 1.0 | GO:0046909 | intermembrane transport(GO:0046909) |
0.3 | 0.3 | GO:0042160 | plasma lipoprotein particle oxidation(GO:0034441) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.3 | 1.7 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.3 | 2.7 | GO:0016322 | neuron remodeling(GO:0016322) |
0.3 | 2.0 | GO:0042491 | auditory receptor cell differentiation(GO:0042491) |
0.3 | 0.7 | GO:1902606 | regulation of large conductance calcium-activated potassium channel activity(GO:1902606) positive regulation of large conductance calcium-activated potassium channel activity(GO:1902608) |
0.3 | 3.3 | GO:0003352 | regulation of cilium movement(GO:0003352) |
0.3 | 2.0 | GO:0048665 | neuron fate specification(GO:0048665) |
0.3 | 0.7 | GO:0090289 | regulation of osteoclast proliferation(GO:0090289) positive regulation of osteoclast proliferation(GO:0090290) |
0.3 | 2.0 | GO:0002934 | desmosome organization(GO:0002934) |
0.3 | 1.0 | GO:1903798 | regulation of production of small RNA involved in gene silencing by RNA(GO:0070920) regulation of production of miRNAs involved in gene silencing by miRNA(GO:1903798) |
0.3 | 0.7 | GO:0060161 | positive regulation of dopamine receptor signaling pathway(GO:0060161) |
0.3 | 8.1 | GO:0055013 | cardiac muscle cell development(GO:0055013) |
0.3 | 0.6 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
0.3 | 0.3 | GO:0003215 | cardiac right ventricle morphogenesis(GO:0003215) |
0.3 | 0.3 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.3 | 0.3 | GO:0048861 | leukemia inhibitory factor signaling pathway(GO:0048861) |
0.3 | 0.3 | GO:0001710 | mesodermal cell fate commitment(GO:0001710) |
0.3 | 0.6 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
0.3 | 0.6 | GO:0046813 | receptor-mediated virion attachment to host cell(GO:0046813) |
0.3 | 0.6 | GO:0045085 | negative regulation of interleukin-2 biosynthetic process(GO:0045085) |
0.3 | 1.6 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
0.3 | 2.2 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.3 | 1.6 | GO:0036158 | outer dynein arm assembly(GO:0036158) |
0.3 | 0.9 | GO:0030321 | transepithelial chloride transport(GO:0030321) |
0.3 | 2.8 | GO:1900119 | positive regulation of execution phase of apoptosis(GO:1900119) |
0.3 | 0.3 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.3 | 3.4 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.3 | 0.6 | GO:0006868 | glutamine transport(GO:0006868) |
0.3 | 0.3 | GO:0019388 | galactose catabolic process(GO:0019388) |
0.3 | 0.3 | GO:0060022 | hard palate development(GO:0060022) |
0.3 | 1.2 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.3 | 1.5 | GO:0048484 | enteric nervous system development(GO:0048484) |
0.3 | 0.3 | GO:0021562 | vestibulocochlear nerve development(GO:0021562) |
0.3 | 0.9 | GO:0032286 | central nervous system myelin maintenance(GO:0032286) |
0.3 | 1.8 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.3 | 0.6 | GO:0072567 | chemokine (C-X-C motif) ligand 2 production(GO:0072567) regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000341) |
0.3 | 0.9 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.3 | 0.6 | GO:0043416 | regulation of skeletal muscle tissue regeneration(GO:0043416) |
0.3 | 8.8 | GO:0030239 | myofibril assembly(GO:0030239) |
0.3 | 0.6 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) |
0.3 | 0.3 | GO:0060083 | smooth muscle contraction involved in micturition(GO:0060083) |
0.3 | 0.3 | GO:0031443 | fast-twitch skeletal muscle fiber contraction(GO:0031443) |
0.3 | 1.5 | GO:0002317 | plasma cell differentiation(GO:0002317) |
0.3 | 0.6 | GO:0002874 | regulation of chronic inflammatory response to antigenic stimulus(GO:0002874) |
0.3 | 1.5 | GO:0030953 | astral microtubule organization(GO:0030953) |
0.3 | 2.1 | GO:0051451 | myoblast migration(GO:0051451) |
0.3 | 0.6 | GO:0032415 | regulation of sodium:proton antiporter activity(GO:0032415) positive regulation of sodium:proton antiporter activity(GO:0032417) |
0.3 | 2.1 | GO:0033574 | response to testosterone(GO:0033574) |
0.3 | 2.1 | GO:0061436 | establishment of skin barrier(GO:0061436) |
0.3 | 0.3 | GO:0034650 | cortisol metabolic process(GO:0034650) |
0.3 | 0.3 | GO:0050975 | sensory perception of touch(GO:0050975) |
0.3 | 0.9 | GO:0006438 | valyl-tRNA aminoacylation(GO:0006438) |
0.3 | 0.6 | GO:1990000 | amyloid fibril formation(GO:1990000) |
0.3 | 1.2 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.3 | 0.9 | GO:0002414 | immunoglobulin transcytosis in epithelial cells(GO:0002414) |
0.3 | 2.0 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.3 | 0.3 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
0.3 | 1.7 | GO:2000052 | positive regulation of non-canonical Wnt signaling pathway(GO:2000052) |
0.3 | 0.3 | GO:0036091 | positive regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0036091) |
0.3 | 0.9 | GO:0045341 | MHC class I biosynthetic process(GO:0045341) regulation of MHC class I biosynthetic process(GO:0045343) positive regulation of MHC class I biosynthetic process(GO:0045345) |
0.3 | 0.3 | GO:1900121 | negative regulation of receptor binding(GO:1900121) |
0.3 | 0.3 | GO:0044650 | virion attachment to host cell(GO:0019062) adhesion of symbiont to host cell(GO:0044650) |
0.3 | 5.9 | GO:0009880 | embryonic pattern specification(GO:0009880) |
0.3 | 0.8 | GO:1900086 | positive regulation of peptidyl-tyrosine autophosphorylation(GO:1900086) |
0.3 | 1.7 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.3 | 0.6 | GO:0043584 | nose development(GO:0043584) |
0.3 | 0.8 | GO:0015860 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.3 | 1.9 | GO:0045109 | intermediate filament organization(GO:0045109) |
0.3 | 1.1 | GO:0015871 | choline transport(GO:0015871) |
0.3 | 0.3 | GO:0014744 | positive regulation of muscle adaptation(GO:0014744) |
0.3 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.6 | GO:1902174 | positive regulation of keratinocyte apoptotic process(GO:1902174) |
0.3 | 0.8 | GO:0035095 | behavioral response to nicotine(GO:0035095) |
0.3 | 0.3 | GO:0060157 | urinary bladder development(GO:0060157) |
0.3 | 0.8 | GO:0034983 | peptidyl-lysine deacetylation(GO:0034983) |
0.3 | 0.8 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
0.3 | 1.6 | GO:0038092 | nodal signaling pathway(GO:0038092) |
0.3 | 0.5 | GO:1904714 | regulation of chaperone-mediated autophagy(GO:1904714) |
0.3 | 1.1 | GO:0010993 | regulation of ubiquitin homeostasis(GO:0010993) free ubiquitin chain polymerization(GO:0010994) |
0.3 | 0.5 | GO:0060023 | soft palate development(GO:0060023) |
0.3 | 1.1 | GO:0098795 | mRNA cleavage involved in gene silencing by miRNA(GO:0035279) mRNA cleavage involved in gene silencing(GO:0098795) |
0.3 | 1.9 | GO:0051546 | keratinocyte migration(GO:0051546) |
0.3 | 1.9 | GO:0070571 | negative regulation of neuron projection regeneration(GO:0070571) |
0.3 | 1.1 | GO:0018101 | protein citrullination(GO:0018101) |
0.3 | 0.3 | GO:0045075 | interleukin-12 biosynthetic process(GO:0042090) regulation of interleukin-12 biosynthetic process(GO:0045075) |
0.3 | 1.9 | GO:0032096 | negative regulation of response to food(GO:0032096) |
0.3 | 0.8 | GO:1990403 | embryonic brain development(GO:1990403) |
0.3 | 1.3 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
0.3 | 1.3 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
0.3 | 0.3 | GO:0022605 | oogenesis stage(GO:0022605) |
0.3 | 0.5 | GO:0033058 | directional locomotion(GO:0033058) |
0.3 | 0.3 | GO:0003309 | type B pancreatic cell differentiation(GO:0003309) |
0.3 | 0.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.3 | 0.5 | GO:0009629 | response to gravity(GO:0009629) |
0.3 | 2.9 | GO:0048714 | positive regulation of oligodendrocyte differentiation(GO:0048714) |
0.3 | 1.3 | GO:0070842 | aggresome assembly(GO:0070842) |
0.3 | 1.0 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
0.3 | 0.3 | GO:0071288 | cellular response to mercury ion(GO:0071288) |
0.3 | 0.8 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.3 | 0.3 | GO:1902953 | positive regulation of ER to Golgi vesicle-mediated transport(GO:1902953) |
0.3 | 0.8 | GO:0070305 | response to cGMP(GO:0070305) |
0.3 | 1.3 | GO:0061298 | retina vasculature development in camera-type eye(GO:0061298) |
0.3 | 0.3 | GO:0006533 | aspartate catabolic process(GO:0006533) |
0.3 | 0.3 | GO:2000344 | positive regulation of acrosome reaction(GO:2000344) |
0.3 | 0.8 | GO:0001865 | NK T cell differentiation(GO:0001865) |
0.3 | 0.5 | GO:0042421 | norepinephrine biosynthetic process(GO:0042421) |
0.3 | 1.0 | GO:0042759 | long-chain fatty acid biosynthetic process(GO:0042759) |
0.3 | 0.3 | GO:0010979 | regulation of vitamin D 24-hydroxylase activity(GO:0010979) positive regulation of vitamin D 24-hydroxylase activity(GO:0010980) |
0.3 | 1.8 | GO:0097062 | dendritic spine maintenance(GO:0097062) |
0.2 | 0.7 | GO:0006553 | lysine metabolic process(GO:0006553) |
0.2 | 7.2 | GO:0030326 | embryonic limb morphogenesis(GO:0030326) embryonic appendage morphogenesis(GO:0035113) |
0.2 | 0.7 | GO:0002426 | immunoglobulin production in mucosal tissue(GO:0002426) |
0.2 | 0.7 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.2 | 4.6 | GO:0030865 | cortical cytoskeleton organization(GO:0030865) |
0.2 | 1.7 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
0.2 | 0.5 | GO:0016198 | axon choice point recognition(GO:0016198) |
0.2 | 0.7 | GO:0038166 | angiotensin-activated signaling pathway(GO:0038166) |
0.2 | 0.7 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.2 | 0.5 | GO:1900109 | regulation of histone H3-K9 dimethylation(GO:1900109) |
0.2 | 0.7 | GO:0070164 | negative regulation of adiponectin secretion(GO:0070164) |
0.2 | 0.2 | GO:2000852 | corticosterone secretion(GO:0035934) regulation of corticosterone secretion(GO:2000852) |
0.2 | 1.7 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.2 | 0.7 | GO:0061370 | testosterone biosynthetic process(GO:0061370) |
0.2 | 1.9 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
0.2 | 0.5 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
0.2 | 1.2 | GO:0006528 | asparagine metabolic process(GO:0006528) |
0.2 | 0.5 | GO:0031000 | response to caffeine(GO:0031000) |
0.2 | 1.4 | GO:0016056 | rhodopsin mediated signaling pathway(GO:0016056) |
0.2 | 0.9 | GO:0040019 | positive regulation of embryonic development(GO:0040019) |
0.2 | 0.2 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.2 | 0.7 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.2 | 0.5 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
0.2 | 1.2 | GO:0071236 | cellular response to antibiotic(GO:0071236) |
0.2 | 1.2 | GO:2001212 | regulation of vasculogenesis(GO:2001212) |
0.2 | 1.2 | GO:1904970 | brush border assembly(GO:1904970) |
0.2 | 0.5 | GO:0023041 | neuronal signal transduction(GO:0023041) |
0.2 | 0.5 | GO:1903421 | regulation of synaptic vesicle recycling(GO:1903421) |
0.2 | 0.2 | GO:0050705 | regulation of interleukin-1 alpha secretion(GO:0050705) |
0.2 | 2.3 | GO:0014850 | response to muscle activity(GO:0014850) |
0.2 | 0.7 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
0.2 | 0.5 | GO:0001983 | baroreceptor response to increased systemic arterial blood pressure(GO:0001983) |
0.2 | 0.7 | GO:0038033 | positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway(GO:0038033) |
0.2 | 1.4 | GO:0016081 | synaptic vesicle docking(GO:0016081) |
0.2 | 0.7 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
0.2 | 0.7 | GO:0032330 | regulation of chondrocyte differentiation(GO:0032330) |
0.2 | 0.7 | GO:0030382 | sperm mitochondrion organization(GO:0030382) |
0.2 | 0.4 | GO:0070094 | positive regulation of glucagon secretion(GO:0070094) |
0.2 | 0.7 | GO:1990928 | response to amino acid starvation(GO:1990928) |
0.2 | 1.8 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 2.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.2 | 0.7 | GO:0071500 | cellular response to nitrosative stress(GO:0071500) |
0.2 | 0.2 | GO:0046838 | phosphorylated carbohydrate dephosphorylation(GO:0046838) |
0.2 | 2.0 | GO:1901385 | regulation of voltage-gated calcium channel activity(GO:1901385) |
0.2 | 0.2 | GO:0042322 | negative regulation of circadian sleep/wake cycle, REM sleep(GO:0042322) |
0.2 | 0.2 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.2 | 0.4 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.4 | GO:0008588 | release of cytoplasmic sequestered NF-kappaB(GO:0008588) |
0.2 | 0.9 | GO:0090557 | establishment of endothelial intestinal barrier(GO:0090557) |
0.2 | 0.4 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.2 | 0.9 | GO:0089711 | L-glutamate transmembrane transport(GO:0089711) |
0.2 | 0.9 | GO:0006991 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.2 | 0.4 | GO:0060339 | negative regulation of type I interferon-mediated signaling pathway(GO:0060339) |
0.2 | 0.2 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
0.2 | 0.6 | GO:0042732 | D-xylose metabolic process(GO:0042732) |
0.2 | 0.8 | GO:2000767 | positive regulation of cytoplasmic translation(GO:2000767) |
0.2 | 0.6 | GO:0015747 | urate transport(GO:0015747) |
0.2 | 1.2 | GO:2000252 | negative regulation of feeding behavior(GO:2000252) |
0.2 | 0.6 | GO:2000359 | regulation of binding of sperm to zona pellucida(GO:2000359) |
0.2 | 0.8 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.2 | 3.9 | GO:0007588 | excretion(GO:0007588) |
0.2 | 1.2 | GO:0006145 | purine nucleobase catabolic process(GO:0006145) |
0.2 | 0.2 | GO:0061738 | late endosomal microautophagy(GO:0061738) |
0.2 | 0.2 | GO:2000097 | regulation of smooth muscle cell-matrix adhesion(GO:2000097) |
0.2 | 0.4 | GO:0032351 | negative regulation of hormone metabolic process(GO:0032351) |
0.2 | 4.9 | GO:0048791 | calcium ion-regulated exocytosis of neurotransmitter(GO:0048791) |
0.2 | 0.4 | GO:1902430 | negative regulation of beta-amyloid formation(GO:1902430) |
0.2 | 0.4 | GO:0015867 | ATP transport(GO:0015867) |
0.2 | 0.8 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
0.2 | 0.4 | GO:0030432 | peristalsis(GO:0030432) |
0.2 | 0.6 | GO:0018364 | peptidyl-glutamine methylation(GO:0018364) |
0.2 | 0.4 | GO:0003344 | pericardium morphogenesis(GO:0003344) |
0.2 | 0.6 | GO:0051025 | negative regulation of immunoglobulin secretion(GO:0051025) |
0.2 | 0.4 | GO:0061002 | negative regulation of dendritic spine morphogenesis(GO:0061002) |
0.2 | 0.6 | GO:1904694 | negative regulation of vascular smooth muscle contraction(GO:1904694) |
0.2 | 1.4 | GO:0090344 | negative regulation of cell aging(GO:0090344) |
0.2 | 0.2 | GO:0086028 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.2 | 2.2 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
0.2 | 1.2 | GO:0048630 | skeletal muscle tissue growth(GO:0048630) |
0.2 | 0.2 | GO:0060279 | positive regulation of ovulation(GO:0060279) |
0.2 | 0.6 | GO:0070244 | negative regulation of thymocyte apoptotic process(GO:0070244) |
0.2 | 2.1 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.2 | 0.6 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.2 | 0.2 | GO:0046877 | regulation of saliva secretion(GO:0046877) positive regulation of saliva secretion(GO:0046878) |
0.2 | 0.6 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 1.7 | GO:0032288 | myelin assembly(GO:0032288) |
0.2 | 0.6 | GO:0046951 | ketone body biosynthetic process(GO:0046951) |
0.2 | 2.8 | GO:0030510 | regulation of BMP signaling pathway(GO:0030510) |
0.2 | 0.6 | GO:0002408 | myeloid dendritic cell chemotaxis(GO:0002408) |
0.2 | 0.4 | GO:0060618 | nipple development(GO:0060618) |
0.2 | 0.2 | GO:0010901 | regulation of very-low-density lipoprotein particle remodeling(GO:0010901) |
0.2 | 0.4 | GO:2000520 | regulation of immunological synapse formation(GO:2000520) |
0.2 | 0.7 | GO:0090666 | scaRNA localization to Cajal body(GO:0090666) |
0.2 | 0.4 | GO:0042091 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.2 | 0.6 | GO:0042045 | epithelial fluid transport(GO:0042045) |
0.2 | 0.4 | GO:2001258 | negative regulation of cation channel activity(GO:2001258) |
0.2 | 0.2 | GO:0046449 | creatinine metabolic process(GO:0046449) cellular lactam metabolic process(GO:0072338) |
0.2 | 0.9 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.2 | 0.9 | GO:1902047 | polyamine transmembrane transport(GO:1902047) regulation of polyamine transmembrane transport(GO:1902267) |
0.2 | 0.2 | GO:0050926 | regulation of positive chemotaxis(GO:0050926) |
0.2 | 1.4 | GO:0034776 | response to histamine(GO:0034776) |
0.2 | 0.4 | GO:0001767 | establishment of lymphocyte polarity(GO:0001767) establishment of T cell polarity(GO:0001768) |
0.2 | 4.8 | GO:0042472 | inner ear morphogenesis(GO:0042472) |
0.2 | 1.1 | GO:0060732 | positive regulation of inositol phosphate biosynthetic process(GO:0060732) |
0.2 | 0.4 | GO:0043402 | glucocorticoid mediated signaling pathway(GO:0043402) |
0.2 | 0.4 | GO:1900102 | negative regulation of endoplasmic reticulum unfolded protein response(GO:1900102) |
0.2 | 0.7 | GO:0035108 | appendage morphogenesis(GO:0035107) limb morphogenesis(GO:0035108) |
0.2 | 1.4 | GO:0043567 | regulation of insulin-like growth factor receptor signaling pathway(GO:0043567) |
0.2 | 0.2 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
0.2 | 0.4 | GO:0043366 | beta selection(GO:0043366) |
0.2 | 0.5 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
0.2 | 0.7 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
0.2 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.2 | 0.3 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.2 | 0.3 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.2 | 0.2 | GO:0060317 | cardiac epithelial to mesenchymal transition(GO:0060317) |
0.2 | 0.3 | GO:0048715 | negative regulation of oligodendrocyte differentiation(GO:0048715) |
0.2 | 0.7 | GO:2001198 | regulation of dendritic cell differentiation(GO:2001198) |
0.2 | 0.2 | GO:1904754 | positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
0.2 | 0.7 | GO:0042447 | hormone catabolic process(GO:0042447) |
0.2 | 1.0 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.2 | 0.8 | GO:0009162 | deoxyribonucleoside monophosphate metabolic process(GO:0009162) |
0.2 | 3.3 | GO:0003341 | cilium movement(GO:0003341) |
0.2 | 0.5 | GO:0007603 | phototransduction, visible light(GO:0007603) |
0.2 | 0.5 | GO:0009240 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) |
0.2 | 2.9 | GO:0002066 | columnar/cuboidal epithelial cell development(GO:0002066) |
0.2 | 0.2 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.2 | 1.8 | GO:0030199 | collagen fibril organization(GO:0030199) |
0.2 | 0.5 | GO:0032252 | secretory granule localization(GO:0032252) |
0.2 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.2 | 0.5 | GO:0035247 | peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.6 | GO:0048539 | bone marrow development(GO:0048539) |
0.2 | 0.3 | GO:0021699 | cerebellar cortex maturation(GO:0021699) |
0.2 | 1.7 | GO:0008272 | sulfate transport(GO:0008272) |
0.2 | 0.2 | GO:0006705 | mineralocorticoid biosynthetic process(GO:0006705) |
0.2 | 0.6 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.2 | 0.2 | GO:0010909 | regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010908) positive regulation of heparan sulfate proteoglycan biosynthetic process(GO:0010909) positive regulation of proteoglycan biosynthetic process(GO:1902730) |
0.2 | 2.5 | GO:0002903 | negative regulation of B cell apoptotic process(GO:0002903) |
0.2 | 0.2 | GO:0003203 | endocardial cushion morphogenesis(GO:0003203) |
0.2 | 0.5 | GO:0006562 | proline catabolic process(GO:0006562) |
0.2 | 0.2 | GO:0018243 | protein O-linked glycosylation via threonine(GO:0018243) |
0.2 | 1.4 | GO:0010842 | retina layer formation(GO:0010842) |
0.2 | 0.6 | GO:0030299 | intestinal cholesterol absorption(GO:0030299) |
0.2 | 0.5 | GO:0006420 | arginyl-tRNA aminoacylation(GO:0006420) |
0.2 | 0.5 | GO:0048483 | autonomic nervous system development(GO:0048483) |
0.2 | 0.2 | GO:0070268 | cornification(GO:0070268) |
0.1 | 0.1 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.1 | 0.4 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.1 | 2.1 | GO:1902668 | negative regulation of axon guidance(GO:1902668) |
0.1 | 0.1 | GO:0098528 | skeletal muscle fiber differentiation(GO:0098528) |
0.1 | 0.6 | GO:0044821 | meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.1 | 0.7 | GO:0035726 | common myeloid progenitor cell proliferation(GO:0035726) |
0.1 | 0.3 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
0.1 | 0.6 | GO:0048643 | positive regulation of skeletal muscle tissue development(GO:0048643) |
0.1 | 2.2 | GO:0051875 | pigment granule localization(GO:0051875) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.3 | GO:0097113 | AMPA glutamate receptor clustering(GO:0097113) glutamate receptor clustering(GO:0097688) |
0.1 | 0.1 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
0.1 | 0.4 | GO:0086069 | bundle of His cell to Purkinje myocyte communication(GO:0086069) |
0.1 | 1.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
0.1 | 1.3 | GO:0033617 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.1 | 0.6 | GO:0002035 | brain renin-angiotensin system(GO:0002035) |
0.1 | 0.1 | GO:0051284 | positive regulation of sequestering of calcium ion(GO:0051284) |
0.1 | 0.7 | GO:0031053 | primary miRNA processing(GO:0031053) |
0.1 | 0.3 | GO:0071895 | odontoblast differentiation(GO:0071895) |
0.1 | 0.4 | GO:0060467 | negative regulation of fertilization(GO:0060467) |
0.1 | 0.7 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.1 | 0.3 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.1 | 0.3 | GO:0000255 | allantoin metabolic process(GO:0000255) |
0.1 | 0.1 | GO:0071910 | determination of liver left/right asymmetry(GO:0071910) |
0.1 | 0.7 | GO:1901317 | regulation of sperm motility(GO:1901317) |
0.1 | 1.3 | GO:0055010 | ventricular cardiac muscle tissue morphogenesis(GO:0055010) |
0.1 | 0.3 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.1 | 0.3 | GO:0071502 | cellular response to temperature stimulus(GO:0071502) |
0.1 | 0.1 | GO:0090335 | regulation of brown fat cell differentiation(GO:0090335) |
0.1 | 0.7 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.1 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.1 | 0.3 | GO:0035511 | oxidative DNA demethylation(GO:0035511) |
0.1 | 0.9 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.1 | 1.2 | GO:0031507 | heterochromatin assembly(GO:0031507) |
0.1 | 0.4 | GO:0009972 | cytidine catabolic process(GO:0006216) cytidine deamination(GO:0009972) cytidine metabolic process(GO:0046087) |
0.1 | 1.3 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) |
0.1 | 0.1 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
0.1 | 0.3 | GO:0060100 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
0.1 | 1.8 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.1 | 0.4 | GO:0071285 | cellular response to lithium ion(GO:0071285) |
0.1 | 6.9 | GO:0007218 | neuropeptide signaling pathway(GO:0007218) |
0.1 | 0.1 | GO:0032741 | positive regulation of interleukin-18 production(GO:0032741) |
0.1 | 0.4 | GO:1903672 | positive regulation of sprouting angiogenesis(GO:1903672) |
0.1 | 1.0 | GO:2000251 | positive regulation of actin cytoskeleton reorganization(GO:2000251) |
0.1 | 3.0 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.1 | 0.2 | GO:0048808 | male genitalia morphogenesis(GO:0048808) male anatomical structure morphogenesis(GO:0090598) |
0.1 | 0.7 | GO:0042481 | regulation of odontogenesis(GO:0042481) |
0.1 | 0.6 | GO:0046643 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
0.1 | 0.5 | GO:0090220 | chromosome localization to nuclear envelope involved in homologous chromosome segregation(GO:0090220) |
0.1 | 1.1 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
0.1 | 2.3 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
0.1 | 0.4 | GO:1990845 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
0.1 | 0.1 | GO:0061511 | centriole elongation(GO:0061511) |
0.1 | 1.0 | GO:0046069 | cGMP catabolic process(GO:0046069) |
0.1 | 0.6 | GO:0030579 | ubiquitin-dependent SMAD protein catabolic process(GO:0030579) |
0.1 | 1.1 | GO:0006907 | pinocytosis(GO:0006907) |
0.1 | 0.2 | GO:0051584 | regulation of dopamine uptake involved in synaptic transmission(GO:0051584) regulation of catecholamine uptake involved in synaptic transmission(GO:0051940) |
0.1 | 0.6 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) |
0.1 | 0.2 | GO:0048014 | Tie signaling pathway(GO:0048014) |
0.1 | 0.4 | GO:1990034 | calcium ion export from cell(GO:1990034) |
0.1 | 0.4 | GO:0033762 | response to glucagon(GO:0033762) |
0.1 | 0.9 | GO:1901741 | positive regulation of myoblast fusion(GO:1901741) |
0.1 | 0.2 | GO:2000354 | regulation of ovarian follicle development(GO:2000354) |
0.1 | 0.7 | GO:0043651 | linoleic acid metabolic process(GO:0043651) |
0.1 | 1.4 | GO:0051127 | positive regulation of actin nucleation(GO:0051127) |
0.1 | 0.1 | GO:1901723 | negative regulation of cell proliferation involved in kidney development(GO:1901723) |
0.1 | 0.3 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
0.1 | 0.8 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.1 | 0.5 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
0.1 | 0.8 | GO:0051085 | chaperone mediated protein folding requiring cofactor(GO:0051085) |
0.1 | 0.3 | GO:0033227 | dsRNA transport(GO:0033227) |
0.1 | 0.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.2 | GO:0007412 | axon target recognition(GO:0007412) |
0.1 | 0.6 | GO:0060907 | positive regulation of macrophage cytokine production(GO:0060907) |
0.1 | 0.8 | GO:0006108 | malate metabolic process(GO:0006108) |
0.1 | 0.1 | GO:2000407 | regulation of T cell extravasation(GO:2000407) |
0.1 | 0.1 | GO:0019532 | oxalate transport(GO:0019532) |
0.1 | 0.2 | GO:0060024 | rhythmic synaptic transmission(GO:0060024) |
0.1 | 0.7 | GO:0001771 | immunological synapse formation(GO:0001771) |
0.1 | 0.4 | GO:0097264 | self proteolysis(GO:0097264) |
0.1 | 0.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
0.1 | 0.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.1 | 0.4 | GO:0033234 | negative regulation of protein sumoylation(GO:0033234) |
0.1 | 0.7 | GO:0032495 | response to muramyl dipeptide(GO:0032495) |
0.1 | 2.4 | GO:0031424 | keratinization(GO:0031424) |
0.1 | 0.3 | GO:0006566 | threonine metabolic process(GO:0006566) |
0.1 | 0.4 | GO:0048304 | positive regulation of isotype switching to IgG isotypes(GO:0048304) |
0.1 | 0.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.1 | 0.3 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
0.1 | 0.1 | GO:2000301 | negative regulation of synaptic vesicle exocytosis(GO:2000301) |
0.1 | 0.8 | GO:0035269 | protein O-linked mannosylation(GO:0035269) |
0.1 | 0.2 | GO:0060914 | heart formation(GO:0060914) |
0.1 | 0.2 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.1 | GO:2000679 | positive regulation of transcription regulatory region DNA binding(GO:2000679) |
0.1 | 0.2 | GO:2000467 | positive regulation of glycogen (starch) synthase activity(GO:2000467) |
0.1 | 0.4 | GO:0009624 | response to nematode(GO:0009624) |
0.1 | 0.4 | GO:0002098 | tRNA wobble uridine modification(GO:0002098) |
0.1 | 1.1 | GO:2001015 | negative regulation of skeletal muscle cell differentiation(GO:2001015) |
0.1 | 0.4 | GO:0043312 | neutrophil degranulation(GO:0043312) |
0.1 | 0.2 | GO:0043553 | negative regulation of phosphatidylinositol 3-kinase activity(GO:0043553) |
0.1 | 0.1 | GO:0046100 | hypoxanthine metabolic process(GO:0046100) hypoxanthine biosynthetic process(GO:0046101) |
0.1 | 1.9 | GO:0001578 | microtubule bundle formation(GO:0001578) |
0.1 | 0.3 | GO:0033566 | gamma-tubulin complex localization(GO:0033566) |
0.1 | 0.3 | GO:0042138 | meiotic DNA double-strand break formation(GO:0042138) |
0.1 | 1.6 | GO:0070207 | protein homotrimerization(GO:0070207) |
0.1 | 0.5 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.1 | 0.3 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
0.1 | 0.7 | GO:0035094 | response to nicotine(GO:0035094) |
0.1 | 0.4 | GO:0006177 | GMP biosynthetic process(GO:0006177) |
0.1 | 0.3 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
0.1 | 1.0 | GO:0048535 | lymph node development(GO:0048535) |
0.1 | 0.4 | GO:0051534 | negative regulation of NFAT protein import into nucleus(GO:0051534) |
0.1 | 0.1 | GO:0007066 | female meiosis sister chromatid cohesion(GO:0007066) |
0.1 | 0.3 | GO:0061084 | negative regulation of protein refolding(GO:0061084) |
0.1 | 0.1 | GO:0021604 | cranial nerve structural organization(GO:0021604) |
0.1 | 0.2 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
0.1 | 0.4 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.1 | 0.3 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.3 | GO:0015888 | thiamine transport(GO:0015888) |
0.1 | 0.5 | GO:0006654 | phosphatidic acid biosynthetic process(GO:0006654) |
0.1 | 0.8 | GO:1902259 | regulation of delayed rectifier potassium channel activity(GO:1902259) |
0.1 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.1 | 0.3 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.1 | 0.1 | GO:0021794 | thalamus development(GO:0021794) |
0.1 | 0.2 | GO:0003197 | endocardial cushion development(GO:0003197) |
0.1 | 0.1 | GO:0090045 | positive regulation of deacetylase activity(GO:0090045) |
0.1 | 0.3 | GO:0006114 | glycerol biosynthetic process(GO:0006114) |
0.1 | 0.2 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.1 | 0.3 | GO:0045625 | regulation of T-helper 1 cell differentiation(GO:0045625) |
0.1 | 0.3 | GO:0072423 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.3 | GO:0019227 | neuronal action potential propagation(GO:0019227) action potential propagation(GO:0098870) |
0.1 | 0.3 | GO:1903553 | positive regulation of extracellular exosome assembly(GO:1903553) |
0.1 | 0.1 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
0.1 | 0.2 | GO:0033689 | negative regulation of osteoblast proliferation(GO:0033689) |
0.1 | 0.3 | GO:0097499 | protein localization to nonmotile primary cilium(GO:0097499) |
0.1 | 0.4 | GO:1901970 | positive regulation of mitotic sister chromatid separation(GO:1901970) |
0.1 | 0.2 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
0.1 | 0.6 | GO:0032735 | positive regulation of interleukin-12 production(GO:0032735) |
0.1 | 0.1 | GO:1900368 | regulation of RNA interference(GO:1900368) |
0.1 | 0.8 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
0.1 | 0.2 | GO:0070125 | mitochondrial translational elongation(GO:0070125) |
0.1 | 0.6 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
0.1 | 0.2 | GO:0021554 | optic nerve development(GO:0021554) |
0.1 | 0.5 | GO:0010666 | positive regulation of striated muscle cell apoptotic process(GO:0010663) positive regulation of cardiac muscle cell apoptotic process(GO:0010666) |
0.1 | 0.2 | GO:0016264 | gap junction assembly(GO:0016264) |
0.1 | 3.4 | GO:0030216 | keratinocyte differentiation(GO:0030216) |
0.1 | 0.1 | GO:0070431 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
0.1 | 0.3 | GO:0023019 | signal transduction involved in regulation of gene expression(GO:0023019) |
0.1 | 0.9 | GO:0045662 | negative regulation of myoblast differentiation(GO:0045662) |
0.1 | 0.5 | GO:0060043 | regulation of cardiac muscle cell proliferation(GO:0060043) |
0.1 | 0.5 | GO:0009071 | serine family amino acid catabolic process(GO:0009071) |
0.1 | 0.2 | GO:0002225 | positive regulation of antimicrobial peptide production(GO:0002225) positive regulation of antibacterial peptide production(GO:0002803) |
0.1 | 0.6 | GO:0035082 | axoneme assembly(GO:0035082) |
0.1 | 0.5 | GO:0071569 | protein ufmylation(GO:0071569) |
0.1 | 0.2 | GO:0051835 | positive regulation of synapse structural plasticity(GO:0051835) |
0.1 | 0.2 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.1 | 0.4 | GO:0051926 | negative regulation of calcium ion transport(GO:0051926) |
0.1 | 1.1 | GO:0060393 | regulation of pathway-restricted SMAD protein phosphorylation(GO:0060393) |
0.1 | 0.2 | GO:0061303 | cornea development in camera-type eye(GO:0061303) |
0.1 | 0.2 | GO:0039692 | single stranded viral RNA replication via double stranded DNA intermediate(GO:0039692) regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.1 | 0.5 | GO:0051026 | chiasma assembly(GO:0051026) |
0.1 | 0.2 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.1 | 0.1 | GO:0051799 | negative regulation of hair follicle development(GO:0051799) |
0.1 | 0.4 | GO:0070327 | thyroid hormone transport(GO:0070327) |
0.1 | 0.1 | GO:0032074 | negative regulation of nuclease activity(GO:0032074) |
0.1 | 0.6 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.4 | GO:0042474 | middle ear morphogenesis(GO:0042474) |
0.1 | 0.3 | GO:0051562 | negative regulation of mitochondrial calcium ion concentration(GO:0051562) |
0.1 | 0.1 | GO:0046607 | positive regulation of centrosome cycle(GO:0046607) |
0.1 | 0.1 | GO:2000667 | positive regulation of interleukin-5 secretion(GO:2000664) positive regulation of interleukin-13 secretion(GO:2000667) |
0.1 | 0.1 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.5 | GO:0002755 | MyD88-dependent toll-like receptor signaling pathway(GO:0002755) |
0.1 | 0.1 | GO:0046499 | S-adenosylmethioninamine metabolic process(GO:0046499) |
0.1 | 0.3 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
0.1 | 0.6 | GO:0060021 | palate development(GO:0060021) |
0.1 | 0.1 | GO:1904238 | pericyte cell differentiation(GO:1904238) |
0.1 | 0.2 | GO:0006419 | alanyl-tRNA aminoacylation(GO:0006419) |
0.1 | 0.6 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.1 | 0.2 | GO:1900040 | regulation of interleukin-2 secretion(GO:1900040) |
0.1 | 0.1 | GO:0042362 | fat-soluble vitamin biosynthetic process(GO:0042362) |
0.1 | 0.2 | GO:1903204 | negative regulation of oxidative stress-induced neuron death(GO:1903204) |
0.1 | 1.1 | GO:0009268 | response to pH(GO:0009268) |
0.1 | 0.4 | GO:0061028 | establishment of endothelial barrier(GO:0061028) |
0.1 | 0.1 | GO:1990314 | cellular response to insulin-like growth factor stimulus(GO:1990314) |
0.1 | 0.1 | GO:0001927 | exocyst assembly(GO:0001927) |
0.1 | 0.3 | GO:0070932 | histone H3 deacetylation(GO:0070932) |
0.1 | 0.3 | GO:0007021 | tubulin complex assembly(GO:0007021) |
0.1 | 0.1 | GO:1900424 | regulation of defense response to bacterium(GO:1900424) |
0.1 | 0.2 | GO:0001780 | neutrophil homeostasis(GO:0001780) |
0.1 | 0.7 | GO:0007141 | male meiosis I(GO:0007141) |
0.1 | 0.5 | GO:0022617 | extracellular matrix disassembly(GO:0022617) |
0.1 | 0.1 | GO:0090399 | replicative senescence(GO:0090399) |
0.1 | 0.1 | GO:0007089 | traversing start control point of mitotic cell cycle(GO:0007089) |
0.1 | 0.2 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.1 | 0.4 | GO:0014002 | astrocyte development(GO:0014002) |
0.1 | 0.2 | GO:0007296 | vitellogenesis(GO:0007296) |
0.1 | 0.1 | GO:0018125 | peptidyl-cysteine methylation(GO:0018125) |
0.1 | 0.1 | GO:0071681 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
0.0 | 0.0 | GO:0090191 | negative regulation of branching involved in ureteric bud morphogenesis(GO:0090191) |
0.0 | 0.0 | GO:0090230 | regulation of centromere complex assembly(GO:0090230) |
0.0 | 0.1 | GO:0010878 | cholesterol storage(GO:0010878) |
0.0 | 2.5 | GO:0007156 | homophilic cell adhesion via plasma membrane adhesion molecules(GO:0007156) |
0.0 | 0.9 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.1 | GO:0060340 | positive regulation of type I interferon-mediated signaling pathway(GO:0060340) |
0.0 | 0.3 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.0 | 0.0 | GO:0009957 | epidermal cell fate specification(GO:0009957) |
0.0 | 0.3 | GO:0045956 | positive regulation of calcium ion-dependent exocytosis(GO:0045956) |
0.0 | 0.4 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.0 | 0.0 | GO:2000253 | positive regulation of feeding behavior(GO:2000253) |
0.0 | 0.6 | GO:0070206 | protein trimerization(GO:0070206) |
0.0 | 0.4 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.0 | 0.4 | GO:0048305 | immunoglobulin secretion(GO:0048305) |
0.0 | 0.7 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
0.0 | 0.1 | GO:0090071 | negative regulation of ribosome biogenesis(GO:0090071) |
0.0 | 0.1 | GO:0034756 | regulation of iron ion transport(GO:0034756) |
0.0 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.0 | 0.1 | GO:0015772 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.0 | 0.1 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.0 | 0.0 | GO:0061724 | lipophagy(GO:0061724) |
0.0 | 0.3 | GO:0001738 | morphogenesis of a polarized epithelium(GO:0001738) |
0.0 | 0.0 | GO:0090394 | negative regulation of excitatory postsynaptic potential(GO:0090394) regulation of retina development in camera-type eye(GO:1902866) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
0.0 | 0.1 | GO:0048733 | sebaceous gland development(GO:0048733) |
0.0 | 0.3 | GO:0002062 | chondrocyte differentiation(GO:0002062) |
0.0 | 0.1 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
0.0 | 0.2 | GO:0015670 | carbon dioxide transport(GO:0015670) |
0.0 | 0.1 | GO:0045880 | positive regulation of smoothened signaling pathway(GO:0045880) |
0.0 | 0.2 | GO:0010890 | positive regulation of sequestering of triglyceride(GO:0010890) |
0.0 | 0.0 | GO:0060478 | acrosomal vesicle exocytosis(GO:0060478) |
0.0 | 0.2 | GO:0051654 | establishment of mitochondrion localization(GO:0051654) |
0.0 | 0.0 | GO:1900019 | regulation of protein kinase C activity(GO:1900019) positive regulation of protein kinase C activity(GO:1900020) |
0.0 | 0.0 | GO:0090238 | positive regulation of arachidonic acid secretion(GO:0090238) |
0.0 | 0.1 | GO:0006532 | aspartate biosynthetic process(GO:0006532) |
0.0 | 0.8 | GO:0031122 | cytoplasmic microtubule organization(GO:0031122) |
0.0 | 0.1 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.0 | 0.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
0.0 | 0.3 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.0 | 0.0 | GO:0031052 | programmed DNA elimination(GO:0031049) chromosome breakage(GO:0031052) |
0.0 | 0.0 | GO:0045590 | negative regulation of regulatory T cell differentiation(GO:0045590) |
0.0 | 0.1 | GO:0060051 | negative regulation of protein glycosylation(GO:0060051) |
0.0 | 0.2 | GO:0019081 | viral translation(GO:0019081) |
0.0 | 0.1 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.0 | 0.3 | GO:0035455 | response to interferon-alpha(GO:0035455) |
0.0 | 0.2 | GO:0044872 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
0.0 | 0.1 | GO:0030647 | polyketide metabolic process(GO:0030638) aminoglycoside antibiotic metabolic process(GO:0030647) daunorubicin metabolic process(GO:0044597) doxorubicin metabolic process(GO:0044598) |
0.0 | 0.0 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.0 | 1.7 | GO:0007601 | visual perception(GO:0007601) |
0.0 | 0.4 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
0.0 | 0.2 | GO:0006707 | cholesterol catabolic process(GO:0006707) sterol catabolic process(GO:0016127) |
0.0 | 0.0 | GO:0036295 | cellular response to increased oxygen levels(GO:0036295) cellular response to hyperoxia(GO:0071455) |
0.0 | 0.1 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
0.0 | 0.1 | GO:0072540 | T-helper 17 cell lineage commitment(GO:0072540) |
0.0 | 0.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.0 | 0.0 | GO:0002835 | negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) |
0.0 | 0.0 | GO:2000271 | positive regulation of fibroblast apoptotic process(GO:2000271) |
0.0 | 0.1 | GO:2000672 | negative regulation of motor neuron apoptotic process(GO:2000672) |
0.0 | 0.3 | GO:0070534 | protein K63-linked ubiquitination(GO:0070534) |
0.0 | 0.0 | GO:1903334 | positive regulation of protein folding(GO:1903334) |
0.0 | 0.1 | GO:0046116 | queuosine biosynthetic process(GO:0008616) queuosine metabolic process(GO:0046116) |
0.0 | 0.0 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.0 | 0.0 | GO:0035567 | non-canonical Wnt signaling pathway(GO:0035567) |
0.0 | 0.0 | GO:2000680 | regulation of rubidium ion transport(GO:2000680) |
0.0 | 0.1 | GO:0009948 | anterior/posterior axis specification(GO:0009948) |
0.0 | 0.0 | GO:0046880 | regulation of follicle-stimulating hormone secretion(GO:0046880) |
0.0 | 0.0 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
0.0 | 0.0 | GO:0060967 | negative regulation of posttranscriptional gene silencing(GO:0060149) negative regulation of gene silencing by RNA(GO:0060967) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
4.5 | 13.4 | GO:0005594 | collagen type IX trimer(GO:0005594) |
2.5 | 20.1 | GO:0005861 | troponin complex(GO:0005861) |
1.7 | 5.1 | GO:1990597 | AIP1-IRE1 complex(GO:1990597) |
1.6 | 18.8 | GO:0005583 | fibrillar collagen trimer(GO:0005583) banded collagen fibril(GO:0098643) |
1.3 | 12.0 | GO:0005859 | muscle myosin complex(GO:0005859) |
1.3 | 2.7 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
1.3 | 3.9 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
1.3 | 5.2 | GO:0071953 | elastic fiber(GO:0071953) |
1.3 | 1.3 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
1.2 | 3.6 | GO:0005608 | laminin-3 complex(GO:0005608) |
1.2 | 4.8 | GO:0036454 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) insulin-like growth factor ternary complex(GO:0042567) |
1.1 | 3.2 | GO:0097512 | cardiac myofibril(GO:0097512) |
1.0 | 6.2 | GO:0090571 | RNA polymerase II transcription repressor complex(GO:0090571) |
1.0 | 13.0 | GO:0033270 | paranode region of axon(GO:0033270) |
1.0 | 5.9 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
1.0 | 2.9 | GO:0005914 | spot adherens junction(GO:0005914) |
1.0 | 3.8 | GO:1990851 | Wnt-Frizzled-LRP5/6 complex(GO:1990851) |
1.0 | 5.7 | GO:0098651 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
0.9 | 3.7 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
0.9 | 16.4 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
0.9 | 0.9 | GO:1990907 | beta-catenin-TCF complex(GO:1990907) |
0.9 | 2.6 | GO:0097058 | CRLF-CLCF1 complex(GO:0097058) |
0.9 | 2.6 | GO:0005610 | laminin-5 complex(GO:0005610) |
0.9 | 0.9 | GO:0005593 | FACIT collagen trimer(GO:0005593) |
0.8 | 13.5 | GO:0005614 | interstitial matrix(GO:0005614) |
0.8 | 4.0 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.8 | 1.5 | GO:0034750 | Scrib-APC-beta-catenin complex(GO:0034750) |
0.8 | 3.1 | GO:0030478 | actin cap(GO:0030478) |
0.7 | 6.1 | GO:0097542 | ciliary tip(GO:0097542) |
0.7 | 3.4 | GO:0031315 | extrinsic component of mitochondrial outer membrane(GO:0031315) |
0.7 | 5.4 | GO:0016460 | myosin II complex(GO:0016460) |
0.7 | 2.0 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.7 | 2.0 | GO:1990393 | 3M complex(GO:1990393) |
0.7 | 5.9 | GO:0005916 | fascia adherens(GO:0005916) |
0.7 | 11.1 | GO:0043034 | costamere(GO:0043034) |
0.6 | 1.9 | GO:0061689 | tricellular tight junction(GO:0061689) |
0.6 | 3.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
0.6 | 18.6 | GO:0016235 | aggresome(GO:0016235) |
0.6 | 203.6 | GO:0005667 | transcription factor complex(GO:0005667) |
0.6 | 1.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
0.6 | 1.7 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.6 | 1.7 | GO:0044393 | microspike(GO:0044393) |
0.5 | 2.7 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.5 | 2.1 | GO:0071438 | invadopodium membrane(GO:0071438) |
0.5 | 4.7 | GO:0043194 | axon initial segment(GO:0043194) |
0.5 | 1.0 | GO:0043256 | laminin complex(GO:0043256) |
0.5 | 0.5 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.5 | 3.1 | GO:0005915 | zonula adherens(GO:0005915) |
0.5 | 9.5 | GO:0005922 | connexon complex(GO:0005922) |
0.5 | 0.5 | GO:0043219 | lateral loop(GO:0043219) |
0.5 | 4.3 | GO:0005751 | mitochondrial respiratory chain complex IV(GO:0005751) |
0.5 | 1.4 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.4 | 6.3 | GO:0036379 | striated muscle thin filament(GO:0005865) myofilament(GO:0036379) |
0.4 | 1.8 | GO:1990696 | USH2 complex(GO:1990696) |
0.4 | 26.1 | GO:0005581 | collagen trimer(GO:0005581) |
0.4 | 2.6 | GO:0001674 | female germ cell nucleus(GO:0001674) |
0.4 | 2.6 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 3.3 | GO:0045179 | apical cortex(GO:0045179) |
0.4 | 3.3 | GO:0035253 | ciliary rootlet(GO:0035253) |
0.4 | 3.7 | GO:0036156 | inner dynein arm(GO:0036156) |
0.4 | 3.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.4 | 1.2 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 4.7 | GO:0005641 | nuclear envelope lumen(GO:0005641) |
0.4 | 1.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
0.4 | 1.9 | GO:0097255 | R2TP complex(GO:0097255) |
0.4 | 26.2 | GO:0005604 | basement membrane(GO:0005604) |
0.4 | 3.5 | GO:1990023 | mitotic spindle midzone(GO:1990023) |
0.4 | 1.2 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
0.4 | 0.4 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
0.4 | 3.0 | GO:0001520 | outer dense fiber(GO:0001520) |
0.4 | 2.6 | GO:0090543 | Flemming body(GO:0090543) |
0.4 | 3.3 | GO:0001527 | microfibril(GO:0001527) |
0.4 | 1.8 | GO:0045180 | basal cortex(GO:0045180) |
0.3 | 3.1 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.3 | 1.4 | GO:0000322 | storage vacuole(GO:0000322) |
0.3 | 0.3 | GO:0031467 | Cul7-RING ubiquitin ligase complex(GO:0031467) |
0.3 | 2.7 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
0.3 | 3.0 | GO:0036128 | CatSper complex(GO:0036128) |
0.3 | 55.6 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.3 | 1.9 | GO:0098533 | ATPase dependent transmembrane transport complex(GO:0098533) |
0.3 | 4.4 | GO:0043196 | varicosity(GO:0043196) |
0.3 | 2.8 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.3 | 0.9 | GO:0014701 | junctional sarcoplasmic reticulum membrane(GO:0014701) |
0.3 | 5.4 | GO:0030057 | desmosome(GO:0030057) |
0.3 | 12.9 | GO:0032432 | actin filament bundle(GO:0032432) |
0.3 | 1.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.3 | 1.7 | GO:0070938 | contractile ring(GO:0070938) |
0.3 | 0.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
0.3 | 1.4 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
0.3 | 3.0 | GO:0035102 | PRC1 complex(GO:0035102) |
0.3 | 2.9 | GO:0017146 | NMDA selective glutamate receptor complex(GO:0017146) |
0.3 | 3.1 | GO:0043240 | Fanconi anaemia nuclear complex(GO:0043240) |
0.3 | 0.8 | GO:0072379 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.3 | 0.5 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
0.3 | 0.3 | GO:0097427 | microtubule bundle(GO:0097427) |
0.3 | 1.5 | GO:0042629 | mast cell granule(GO:0042629) |
0.3 | 0.8 | GO:0035838 | growing cell tip(GO:0035838) |
0.2 | 0.7 | GO:0043293 | apoptosome(GO:0043293) |
0.2 | 0.7 | GO:0097149 | centralspindlin complex(GO:0097149) |
0.2 | 0.5 | GO:0031983 | vesicle lumen(GO:0031983) |
0.2 | 0.7 | GO:0033185 | dolichol-phosphate-mannose synthase complex(GO:0033185) |
0.2 | 11.0 | GO:0030315 | T-tubule(GO:0030315) |
0.2 | 1.2 | GO:0005638 | lamin filament(GO:0005638) |
0.2 | 0.7 | GO:0048179 | activin receptor complex(GO:0048179) |
0.2 | 2.3 | GO:0034706 | sodium channel complex(GO:0034706) |
0.2 | 9.1 | GO:0045095 | keratin filament(GO:0045095) |
0.2 | 0.9 | GO:0070545 | PeBoW complex(GO:0070545) |
0.2 | 3.9 | GO:0005892 | acetylcholine-gated channel complex(GO:0005892) |
0.2 | 2.0 | GO:0008074 | guanylate cyclase complex, soluble(GO:0008074) |
0.2 | 0.9 | GO:0097452 | GAIT complex(GO:0097452) |
0.2 | 0.9 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.2 | 0.2 | GO:0034991 | nuclear meiotic cohesin complex(GO:0034991) |
0.2 | 0.6 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
0.2 | 0.8 | GO:0042582 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
0.2 | 0.6 | GO:0036194 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.2 | 0.8 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
0.2 | 0.4 | GO:0031074 | nucleocytoplasmic shuttling complex(GO:0031074) |
0.2 | 0.2 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
0.2 | 0.6 | GO:0016939 | kinesin II complex(GO:0016939) |
0.2 | 1.5 | GO:0097470 | ribbon synapse(GO:0097470) |
0.2 | 0.9 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.2 | 0.9 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.2 | 0.9 | GO:0031314 | extrinsic component of mitochondrial inner membrane(GO:0031314) |
0.2 | 0.9 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.2 | 1.8 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.2 | 0.9 | GO:0071547 | piP-body(GO:0071547) |
0.2 | 1.2 | GO:0060091 | kinocilium(GO:0060091) |
0.2 | 6.1 | GO:0005834 | heterotrimeric G-protein complex(GO:0005834) |
0.2 | 0.3 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
0.2 | 15.5 | GO:0030016 | myofibril(GO:0030016) |
0.2 | 0.7 | GO:1990726 | Lsm1-7-Pat1 complex(GO:1990726) |
0.2 | 3.1 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.2 | 5.8 | GO:0005844 | polysome(GO:0005844) |
0.2 | 0.6 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.2 | 0.6 | GO:0030015 | CCR4-NOT core complex(GO:0030015) |
0.2 | 3.9 | GO:0045178 | basal part of cell(GO:0045178) |
0.2 | 1.2 | GO:0005677 | chromatin silencing complex(GO:0005677) |
0.2 | 0.8 | GO:0036056 | filtration diaphragm(GO:0036056) slit diaphragm(GO:0036057) |
0.1 | 8.0 | GO:0031012 | extracellular matrix(GO:0031012) |
0.1 | 0.4 | GO:0097342 | ripoptosome(GO:0097342) |
0.1 | 0.6 | GO:0005796 | Golgi lumen(GO:0005796) |
0.1 | 1.6 | GO:0032426 | stereocilium tip(GO:0032426) |
0.1 | 2.2 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.1 | 0.3 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
0.1 | 1.2 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
0.1 | 1.4 | GO:0018995 | host(GO:0018995) host cell part(GO:0033643) host cell(GO:0043657) |
0.1 | 0.5 | GO:0045009 | melanosome membrane(GO:0033162) chitosome(GO:0045009) |
0.1 | 0.3 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.1 | 0.4 | GO:0044194 | cytolytic granule(GO:0044194) |
0.1 | 2.6 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.1 | 0.7 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
0.1 | 0.4 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.1 | 1.5 | GO:0097225 | sperm midpiece(GO:0097225) |
0.1 | 0.6 | GO:0071546 | pi-body(GO:0071546) |
0.1 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
0.1 | 0.3 | GO:0044215 | other organism(GO:0044215) other organism cell(GO:0044216) other organism part(GO:0044217) |
0.1 | 0.3 | GO:0031091 | platelet alpha granule(GO:0031091) |
0.1 | 6.1 | GO:0031526 | brush border membrane(GO:0031526) |
0.1 | 2.1 | GO:0045334 | clathrin-coated endocytic vesicle(GO:0045334) |
0.1 | 0.8 | GO:0016272 | prefoldin complex(GO:0016272) |
0.1 | 1.4 | GO:0000800 | lateral element(GO:0000800) |
0.1 | 0.3 | GO:0097443 | sorting endosome(GO:0097443) |
0.1 | 0.8 | GO:0030123 | AP-3 adaptor complex(GO:0030123) |
0.1 | 0.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.1 | 1.1 | GO:0031083 | BLOC-1 complex(GO:0031083) |
0.1 | 2.8 | GO:0042383 | sarcolemma(GO:0042383) |
0.1 | 0.4 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
0.1 | 0.1 | GO:0005955 | calcineurin complex(GO:0005955) |
0.1 | 7.4 | GO:0043296 | apical junction complex(GO:0043296) |
0.1 | 0.8 | GO:0000782 | telomere cap complex(GO:0000782) nuclear telomere cap complex(GO:0000783) |
0.1 | 0.2 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
0.1 | 0.2 | GO:0098536 | deuterosome(GO:0098536) |
0.1 | 0.1 | GO:0016012 | dystroglycan complex(GO:0016011) sarcoglycan complex(GO:0016012) |
0.1 | 1.1 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.1 | 0.2 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.1 | 0.1 | GO:0070765 | gamma-secretase complex(GO:0070765) |
0.1 | 0.4 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
0.1 | 0.3 | GO:1990745 | EARP complex(GO:1990745) |
0.1 | 0.3 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
0.1 | 0.4 | GO:0030896 | checkpoint clamp complex(GO:0030896) |
0.1 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.1 | 0.2 | GO:0035061 | interchromatin granule(GO:0035061) |
0.1 | 0.1 | GO:0000172 | ribonuclease MRP complex(GO:0000172) |
0.1 | 0.5 | GO:0042587 | glycogen granule(GO:0042587) |
0.1 | 0.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.1 | 1.6 | GO:0031901 | early endosome membrane(GO:0031901) |
0.1 | 1.0 | GO:0001741 | XY body(GO:0001741) |
0.1 | 0.2 | GO:0005688 | U6 snRNP(GO:0005688) |
0.1 | 0.4 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.1 | 0.4 | GO:0071439 | clathrin complex(GO:0071439) |
0.1 | 1.0 | GO:0042470 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.1 | 0.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.1 | 0.3 | GO:0042641 | actomyosin(GO:0042641) |
0.1 | 0.2 | GO:0042825 | TAP complex(GO:0042825) |
0.0 | 0.4 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.0 | 1.8 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.0 | 0.8 | GO:0005839 | proteasome core complex(GO:0005839) |
0.0 | 0.8 | GO:1902710 | GABA receptor complex(GO:1902710) GABA-A receptor complex(GO:1902711) |
0.0 | 0.0 | GO:0000125 | PCAF complex(GO:0000125) |
0.0 | 0.3 | GO:0002102 | podosome(GO:0002102) |
0.0 | 0.3 | GO:0031512 | motile primary cilium(GO:0031512) |
0.0 | 0.2 | GO:0035339 | SPOTS complex(GO:0035339) |
0.0 | 0.2 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.0 | 4.1 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.0 | 2.8 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.0 | 0.1 | GO:1990423 | RZZ complex(GO:1990423) |
0.0 | 1.1 | GO:0005871 | kinesin complex(GO:0005871) |
0.0 | 1.0 | GO:0036126 | sperm flagellum(GO:0036126) |
0.0 | 0.2 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.0 | 0.5 | GO:0044453 | nuclear membrane part(GO:0044453) |
0.0 | 0.2 | GO:0048476 | Holliday junction resolvase complex(GO:0048476) |
0.0 | 6.7 | GO:0030055 | cell-substrate junction(GO:0030055) |
0.0 | 1.1 | GO:0005903 | brush border(GO:0005903) |
0.0 | 0.1 | GO:0072558 | NLRP1 inflammasome complex(GO:0072558) |
0.0 | 1.0 | GO:0000315 | organellar large ribosomal subunit(GO:0000315) mitochondrial large ribosomal subunit(GO:0005762) |
0.0 | 0.3 | GO:0031045 | dense core granule(GO:0031045) |
0.0 | 0.1 | GO:0002189 | ribose phosphate diphosphokinase complex(GO:0002189) |
0.0 | 1.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.1 | GO:0042382 | paraspeckles(GO:0042382) |
0.0 | 0.1 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
0.0 | 2.5 | GO:0031225 | anchored component of membrane(GO:0031225) |
0.0 | 0.1 | GO:0034388 | Pwp2p-containing subcomplex of 90S preribosome(GO:0034388) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.9 | GO:0001533 | cornified envelope(GO:0001533) |
0.0 | 0.3 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
0.0 | 0.1 | GO:0000788 | nuclear nucleosome(GO:0000788) |
0.0 | 0.7 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.6 | GO:0005901 | caveola(GO:0005901) |
0.0 | 0.1 | GO:0097441 | basilar dendrite(GO:0097441) |
0.0 | 0.0 | GO:0044462 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
0.0 | 12.8 | GO:0005615 | extracellular space(GO:0005615) |
0.0 | 0.1 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.7 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.0 | 0.0 | GO:0061574 | ASAP complex(GO:0061574) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.2 | 9.5 | GO:0030172 | troponin C binding(GO:0030172) |
3.1 | 9.3 | GO:1902282 | voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization(GO:1902282) |
2.8 | 8.4 | GO:0008401 | retinoic acid 4-hydroxylase activity(GO:0008401) |
2.6 | 18.2 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
2.3 | 6.8 | GO:0008449 | N-acetylglucosamine-6-sulfatase activity(GO:0008449) |
2.1 | 12.6 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
2.0 | 4.0 | GO:0044323 | retinoic acid-responsive element binding(GO:0044323) |
2.0 | 23.9 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.9 | 5.6 | GO:0070915 | lysophosphatidic acid receptor activity(GO:0070915) |
1.8 | 9.1 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
1.7 | 5.2 | GO:0035939 | microsatellite binding(GO:0035939) |
1.6 | 4.7 | GO:0005219 | ryanodine-sensitive calcium-release channel activity(GO:0005219) |
1.5 | 4.6 | GO:0031014 | troponin T binding(GO:0031014) |
1.5 | 6.0 | GO:0005042 | netrin receptor activity(GO:0005042) |
1.5 | 8.8 | GO:0005005 | transmembrane-ephrin receptor activity(GO:0005005) |
1.4 | 7.0 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
1.4 | 12.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
1.4 | 5.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
1.3 | 4.0 | GO:0051373 | FATZ binding(GO:0051373) |
1.3 | 3.9 | GO:0051718 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) DNA (cytosine-5-)-methyltransferase activity, acting on CpG substrates(GO:0051718) |
1.3 | 6.4 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.3 | 3.8 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
1.3 | 3.8 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.2 | 1.2 | GO:0004104 | cholinesterase activity(GO:0004104) |
1.2 | 6.1 | GO:0003680 | AT DNA binding(GO:0003680) |
1.2 | 8.2 | GO:0031432 | titin binding(GO:0031432) |
1.2 | 3.5 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.2 | 4.6 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
1.1 | 27.1 | GO:0001106 | RNA polymerase II transcription corepressor activity(GO:0001106) |
1.1 | 1.1 | GO:0015137 | citrate transmembrane transporter activity(GO:0015137) tricarboxylic acid transmembrane transporter activity(GO:0015142) |
1.1 | 7.7 | GO:0051371 | muscle alpha-actinin binding(GO:0051371) |
1.1 | 3.3 | GO:0035373 | chondroitin sulfate proteoglycan binding(GO:0035373) |
1.1 | 11.9 | GO:0070700 | BMP receptor binding(GO:0070700) |
1.1 | 24.7 | GO:0071837 | HMG box domain binding(GO:0071837) |
1.1 | 9.6 | GO:0038191 | neuropilin binding(GO:0038191) |
1.0 | 7.3 | GO:0031995 | insulin-like growth factor II binding(GO:0031995) |
1.0 | 5.2 | GO:0071253 | connexin binding(GO:0071253) |
1.0 | 5.0 | GO:0047391 | alkylglycerophosphoethanolamine phosphodiesterase activity(GO:0047391) |
1.0 | 3.0 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
1.0 | 4.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 37.3 | GO:0005109 | frizzled binding(GO:0005109) |
1.0 | 4.8 | GO:0035033 | histone deacetylase regulator activity(GO:0035033) |
0.9 | 2.8 | GO:0005006 | epidermal growth factor-activated receptor activity(GO:0005006) |
0.9 | 3.6 | GO:0070051 | fibrinogen binding(GO:0070051) |
0.9 | 2.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
0.9 | 1.8 | GO:0030297 | transmembrane receptor protein tyrosine kinase activator activity(GO:0030297) |
0.9 | 2.7 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
0.9 | 2.6 | GO:0005127 | ciliary neurotrophic factor receptor binding(GO:0005127) |
0.9 | 4.3 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.9 | 6.8 | GO:0005167 | neurotrophin TRK receptor binding(GO:0005167) |
0.8 | 0.8 | GO:0043394 | proteoglycan binding(GO:0043394) |
0.8 | 2.5 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.8 | 2.5 | GO:0016361 | activin receptor activity, type I(GO:0016361) |
0.8 | 2.5 | GO:0004517 | nitric-oxide synthase activity(GO:0004517) |
0.8 | 1.6 | GO:0030160 | GKAP/Homer scaffold activity(GO:0030160) |
0.8 | 1.6 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.8 | 1.6 | GO:0097603 | temperature-gated ion channel activity(GO:0097603) |
0.8 | 3.2 | GO:0038064 | collagen receptor activity(GO:0038064) |
0.8 | 1.6 | GO:0034739 | histone deacetylase activity (H4-K16 specific)(GO:0034739) |
0.8 | 2.3 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.8 | 35.2 | GO:0098811 | transcriptional activator activity, RNA polymerase II transcription factor binding(GO:0001190) transcriptional repressor activity, RNA polymerase II activating transcription factor binding(GO:0098811) |
0.7 | 17.1 | GO:0017147 | Wnt-protein binding(GO:0017147) |
0.7 | 3.0 | GO:0048185 | activin binding(GO:0048185) |
0.7 | 3.7 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.7 | 1.4 | GO:0035727 | lysophosphatidic acid binding(GO:0035727) |
0.7 | 2.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.7 | 3.6 | GO:0043237 | laminin-1 binding(GO:0043237) |
0.7 | 2.8 | GO:0009374 | biotin binding(GO:0009374) |
0.7 | 2.1 | GO:0004528 | phosphodiesterase I activity(GO:0004528) |
0.7 | 2.1 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
0.7 | 1.4 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
0.7 | 6.0 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
0.7 | 1.3 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.7 | 3.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
0.6 | 1.9 | GO:0086008 | voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization(GO:0086008) |
0.6 | 1.9 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.6 | 1.9 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.6 | 0.6 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
0.6 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.6 | 2.5 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
0.6 | 1.9 | GO:0004103 | choline kinase activity(GO:0004103) |
0.6 | 0.6 | GO:0005001 | transmembrane receptor protein tyrosine phosphatase activity(GO:0005001) |
0.6 | 1.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
0.6 | 1.8 | GO:0019797 | procollagen-proline 3-dioxygenase activity(GO:0019797) |
0.6 | 4.9 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
0.6 | 2.4 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
0.6 | 4.2 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.6 | 1.8 | GO:0051870 | methotrexate binding(GO:0051870) |
0.6 | 2.4 | GO:0030274 | LIM domain binding(GO:0030274) |
0.6 | 1.8 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.6 | 1.8 | GO:0005502 | 11-cis retinal binding(GO:0005502) |
0.6 | 1.8 | GO:0008332 | low voltage-gated calcium channel activity(GO:0008332) |
0.6 | 4.6 | GO:0000983 | transcription factor activity, RNA polymerase II core promoter sequence-specific(GO:0000983) |
0.6 | 1.7 | GO:0046976 | histone methyltransferase activity (H3-K27 specific)(GO:0046976) |
0.6 | 4.6 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.6 | 2.3 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.6 | 5.7 | GO:0008504 | monoamine transmembrane transporter activity(GO:0008504) |
0.6 | 5.1 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
0.6 | 2.2 | GO:0008046 | axon guidance receptor activity(GO:0008046) |
0.6 | 2.2 | GO:0004656 | procollagen-proline 4-dioxygenase activity(GO:0004656) |
0.5 | 1.6 | GO:0071553 | uridine nucleotide receptor activity(GO:0015065) G-protein coupled pyrimidinergic nucleotide receptor activity(GO:0071553) |
0.5 | 2.2 | GO:0005024 | transforming growth factor beta-activated receptor activity(GO:0005024) |
0.5 | 5.9 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.5 | 1.6 | GO:0015141 | succinate transmembrane transporter activity(GO:0015141) |
0.5 | 2.7 | GO:0038132 | neuregulin binding(GO:0038132) |
0.5 | 2.6 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.5 | 8.4 | GO:0070888 | E-box binding(GO:0070888) |
0.5 | 2.1 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.5 | 6.3 | GO:0030546 | receptor activator activity(GO:0030546) |
0.5 | 3.2 | GO:0001191 | transcriptional repressor activity, RNA polymerase II transcription factor binding(GO:0001191) |
0.5 | 1.6 | GO:0004365 | glyceraldehyde-3-phosphate dehydrogenase (NAD+) (phosphorylating) activity(GO:0004365) glyceraldehyde-3-phosphate dehydrogenase (NAD(P)+) (phosphorylating) activity(GO:0043891) |
0.5 | 6.1 | GO:0015026 | coreceptor activity(GO:0015026) |
0.5 | 4.1 | GO:0005523 | tropomyosin binding(GO:0005523) |
0.5 | 3.0 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
0.5 | 1.5 | GO:0004967 | glucagon receptor activity(GO:0004967) |
0.5 | 26.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.5 | 1.4 | GO:1990715 | mRNA CDS binding(GO:1990715) |
0.5 | 1.4 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.5 | 0.9 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.5 | 1.4 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 1.9 | GO:0031781 | melanocortin receptor binding(GO:0031779) type 3 melanocortin receptor binding(GO:0031781) type 4 melanocortin receptor binding(GO:0031782) |
0.5 | 2.3 | GO:0001601 | peptide YY receptor activity(GO:0001601) |
0.5 | 10.7 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.5 | 38.5 | GO:0001078 | transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0001078) |
0.5 | 2.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.5 | 5.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.5 | 0.5 | GO:0005119 | smoothened binding(GO:0005119) hedgehog family protein binding(GO:0097108) |
0.5 | 1.8 | GO:0034889 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.5 | 1.4 | GO:0001161 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) |
0.5 | 21.7 | GO:0003705 | transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0003705) |
0.4 | 1.8 | GO:0030957 | Tat protein binding(GO:0030957) |
0.4 | 2.7 | GO:0047498 | calcium-dependent phospholipase A2 activity(GO:0047498) |
0.4 | 2.2 | GO:0070411 | I-SMAD binding(GO:0070411) |
0.4 | 0.4 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
0.4 | 1.3 | GO:0008502 | melatonin receptor activity(GO:0008502) |
0.4 | 2.2 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.4 | 80.1 | GO:0000982 | transcription factor activity, RNA polymerase II core promoter proximal region sequence-specific binding(GO:0000982) |
0.4 | 5.2 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
0.4 | 7.4 | GO:0003785 | actin monomer binding(GO:0003785) |
0.4 | 2.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.4 | 2.6 | GO:0031419 | cobalamin binding(GO:0031419) |
0.4 | 1.3 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
0.4 | 2.1 | GO:0005113 | patched binding(GO:0005113) |
0.4 | 5.9 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.4 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.4 | 0.8 | GO:0043199 | sulfate binding(GO:0043199) |
0.4 | 2.9 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.4 | 1.2 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
0.4 | 0.4 | GO:0016649 | electron-transferring-flavoprotein dehydrogenase activity(GO:0004174) oxidoreductase activity, acting on the CH-NH group of donors, quinone or similar compound as acceptor(GO:0016649) |
0.4 | 1.6 | GO:0048495 | Roundabout binding(GO:0048495) |
0.4 | 4.1 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.4 | 2.0 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.4 | 3.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 0.4 | GO:0004966 | galanin receptor activity(GO:0004966) |
0.4 | 3.6 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
0.4 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.4 | 1.6 | GO:0032027 | myosin light chain binding(GO:0032027) |
0.4 | 4.6 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.4 | 0.8 | GO:0036403 | 2,3-dihydroxy DDT 1,2-dioxygenase activity(GO:0018542) phenanthrene dioxygenase activity(GO:0018555) 2,2',3-trihydroxybiphenyl dioxygenase activity(GO:0018556) 1,2-dihydroxyfluorene 1,1-alpha-dioxygenase activity(GO:0018557) 5,6-dihydroxy-3-methyl-2-oxo-1,2-dihydroquinoline dioxygenase activity(GO:0018558) 1,1-dichloro-2-(dihydroxy-4-chlorophenyl)-(4-chlorophenyl)ethene 1,2-dioxygenase activity(GO:0018559) protocatechuate 3,4-dioxygenase type II activity(GO:0018560) 2'-aminobiphenyl-2,3-diol 1,2-dioxygenase activity(GO:0018561) 3,4-dihydroxyfluorene 4,4-alpha-dioxygenase activity(GO:0018562) 2,3-dihydroxy-ethylbenzene 1,2-dioxygenase activity(GO:0018563) carbazole 1,9a-dioxygenase activity(GO:0018564) dihydroxydibenzothiophene dioxygenase activity(GO:0018565) 1,2-dihydroxynaphthalene-6-sulfonate 1,8a-dioxygenase activity(GO:0018566) styrene dioxygenase activity(GO:0018567) 3,4-dihydroxyphenanthrene dioxygenase activity(GO:0018568) hydroquinone 1,2-dioxygenase activity(GO:0018569) p-cumate 2,3-dioxygenase activity(GO:0018570) 2,3-dihydroxy-p-cumate dioxygenase activity(GO:0018571) 3,5-dichlorocatechol 1,2-dioxygenase activity(GO:0018572) 2-aminophenol 1,6-dioxygenase activity(GO:0018573) 2,6-dichloro-p-hydroquinone 1,2-dioxygenase activity(GO:0018574) chlorocatechol 1,2-dioxygenase activity(GO:0018575) catechol dioxygenase activity(GO:0019114) dihydroxyfluorene dioxygenase activity(GO:0019117) 5-aminosalicylate dioxygenase activity(GO:0034543) 3-hydroxy-2-naphthoate 2,3-dioxygenase activity(GO:0034803) benzo(a)pyrene 11,12-dioxygenase activity(GO:0034806) benzo(a)pyrene 4,5-dioxygenase activity(GO:0034808) 4,5-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034810) benzo(a)pyrene 9,10-dioxygenase activity(GO:0034811) 9,10-dihydroxybenzo(a)pyrene dioxygenase activity(GO:0034812) benzo(a)pyrene 7,8-dioxygenase activity(GO:0034813) 7,8-dihydroxy benzo(a)pyrene dioxygenase activity(GO:0034814) 1,2-dihydroxy-5,6,7,8-tetrahydronaphthalene extradiol dioxygenase activity(GO:0034827) 2-mercaptobenzothiazole dioxygenase activity(GO:0034834) pyridine-3,4-diol dioxygenase activity(GO:0034895) pyrene dioxygenase activity(GO:0034920) 4,5-dihydroxypyrene dioxygenase activity(GO:0034922) phenanthrene-4-carboxylate dioxygenase activity(GO:0034934) tetrachlorobenzene dioxygenase activity(GO:0034935) 4,6-dichloro-3-methylcatechol 1,2-dioxygenase activity(GO:0034936) 2,3-dihydroxydiphenyl ether dioxygenase activity(GO:0034955) diphenyl ether 1,2-dioxygenase activity(GO:0034956) arachidonate 8(S)-lipoxygenase activity(GO:0036403) 4-hydroxycatechol 1,2-dioxygenase activity(GO:0047074) |
0.4 | 1.5 | GO:0001642 | group III metabotropic glutamate receptor activity(GO:0001642) |
0.4 | 1.1 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
0.4 | 0.4 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
0.4 | 2.6 | GO:0043912 | D-lysine oxidase activity(GO:0043912) |
0.4 | 7.9 | GO:0005104 | fibroblast growth factor receptor binding(GO:0005104) |
0.4 | 1.1 | GO:0045504 | dynein heavy chain binding(GO:0045504) |
0.4 | 1.8 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
0.4 | 2.9 | GO:0044548 | S100 protein binding(GO:0044548) |
0.4 | 1.8 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.4 | 1.4 | GO:0055131 | C3HC4-type RING finger domain binding(GO:0055131) |
0.4 | 0.4 | GO:0008142 | oxysterol binding(GO:0008142) |
0.4 | 1.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.4 | 1.4 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.4 | 2.1 | GO:0018502 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
0.4 | 1.1 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.4 | 1.1 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 174.1 | GO:0043565 | sequence-specific DNA binding(GO:0043565) |
0.4 | 1.4 | GO:0019855 | calcium channel inhibitor activity(GO:0019855) |
0.3 | 3.1 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
0.3 | 2.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
0.3 | 1.4 | GO:0004035 | alkaline phosphatase activity(GO:0004035) |
0.3 | 1.0 | GO:0031750 | D3 dopamine receptor binding(GO:0031750) |
0.3 | 1.3 | GO:0008486 | diphosphoinositol-polyphosphate diphosphatase activity(GO:0008486) |
0.3 | 0.3 | GO:0034056 | estrogen response element binding(GO:0034056) |
0.3 | 5.0 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.3 | 2.7 | GO:0005003 | ephrin receptor activity(GO:0005003) |
0.3 | 1.6 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.3 | 0.3 | GO:0004985 | opioid receptor activity(GO:0004985) |
0.3 | 1.3 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.3 | 2.9 | GO:0035198 | miRNA binding(GO:0035198) |
0.3 | 1.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.3 | 5.8 | GO:0004889 | acetylcholine-activated cation-selective channel activity(GO:0004889) |
0.3 | 6.7 | GO:0071855 | neuropeptide receptor binding(GO:0071855) |
0.3 | 9.8 | GO:0005201 | extracellular matrix structural constituent(GO:0005201) |
0.3 | 0.9 | GO:0004082 | bisphosphoglycerate mutase activity(GO:0004082) phosphoglycerate mutase activity(GO:0004619) 2,3-bisphosphoglycerate-dependent phosphoglycerate mutase activity(GO:0046538) |
0.3 | 0.9 | GO:0070052 | collagen V binding(GO:0070052) |
0.3 | 0.9 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
0.3 | 0.9 | GO:0004952 | dopamine neurotransmitter receptor activity(GO:0004952) |
0.3 | 2.1 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.3 | 2.4 | GO:0043236 | laminin binding(GO:0043236) |
0.3 | 5.7 | GO:0004714 | transmembrane receptor protein tyrosine kinase activity(GO:0004714) |
0.3 | 0.6 | GO:0031871 | proteinase activated receptor binding(GO:0031871) |
0.3 | 1.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
0.3 | 1.2 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
0.3 | 2.0 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.3 | 0.9 | GO:0004832 | valine-tRNA ligase activity(GO:0004832) |
0.3 | 1.1 | GO:0005534 | galactose binding(GO:0005534) |
0.3 | 0.6 | GO:0031433 | telethonin binding(GO:0031433) |
0.3 | 3.6 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.3 | 0.5 | GO:1901702 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
0.3 | 0.8 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
0.3 | 0.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
0.3 | 0.8 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.3 | 3.0 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.3 | 1.1 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 3.2 | GO:0047555 | 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
0.3 | 0.8 | GO:0004946 | bombesin receptor activity(GO:0004946) |
0.3 | 0.8 | GO:0004470 | malic enzyme activity(GO:0004470) malate dehydrogenase (decarboxylating) (NAD+) activity(GO:0004471) |
0.3 | 4.2 | GO:0005528 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.3 | 0.5 | GO:0004090 | carbonyl reductase (NADPH) activity(GO:0004090) |
0.3 | 1.5 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.3 | 0.3 | GO:0015922 | aspartate oxidase activity(GO:0015922) |
0.3 | 2.0 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
0.3 | 2.0 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.3 | 0.5 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
0.2 | 1.0 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.2 | 1.2 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
0.2 | 2.4 | GO:0050840 | extracellular matrix binding(GO:0050840) |
0.2 | 0.2 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.2 | 2.9 | GO:0005112 | Notch binding(GO:0005112) |
0.2 | 9.4 | GO:0005544 | calcium-dependent phospholipid binding(GO:0005544) |
0.2 | 0.7 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
0.2 | 1.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.2 | 1.0 | GO:0045340 | mercury ion binding(GO:0045340) |
0.2 | 0.7 | GO:0008260 | 3-oxoacid CoA-transferase activity(GO:0008260) |
0.2 | 2.8 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.2 | 3.4 | GO:1990939 | ATP-dependent microtubule motor activity(GO:1990939) |
0.2 | 1.6 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 1.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
0.2 | 2.4 | GO:0046977 | TAP binding(GO:0046977) |
0.2 | 3.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.2 | 1.1 | GO:0036122 | BMP binding(GO:0036122) |
0.2 | 2.6 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.2 | 4.8 | GO:0016675 | oxidoreductase activity, acting on a heme group of donors(GO:0016675) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 1.3 | GO:0004972 | NMDA glutamate receptor activity(GO:0004972) |
0.2 | 1.5 | GO:0034526 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.2 | 21.4 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.2 | 0.8 | GO:0004673 | protein histidine kinase activity(GO:0004673) |
0.2 | 0.2 | GO:0070878 | primary miRNA binding(GO:0070878) |
0.2 | 1.9 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
0.2 | 1.2 | GO:0070182 | DNA polymerase binding(GO:0070182) |
0.2 | 1.8 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.2 | 1.0 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.2 | 1.2 | GO:0015280 | ligand-gated sodium channel activity(GO:0015280) |
0.2 | 0.2 | GO:0001224 | RNA polymerase II transcription cofactor binding(GO:0001224) RNA polymerase II transcription corepressor binding(GO:0001226) |
0.2 | 0.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.2 | 0.6 | GO:0004995 | tachykinin receptor activity(GO:0004995) |
0.2 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.2 | 1.5 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.2 | 0.4 | GO:0033265 | choline binding(GO:0033265) |
0.2 | 1.0 | GO:0071723 | lipopeptide binding(GO:0071723) |
0.2 | 2.3 | GO:0097506 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
0.2 | 0.8 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.2 | 0.2 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.2 | 0.8 | GO:0051022 | Rho GDP-dissociation inhibitor binding(GO:0051022) |
0.2 | 0.6 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.2 | 0.7 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
0.2 | 1.9 | GO:0051393 | alpha-actinin binding(GO:0051393) |
0.2 | 0.9 | GO:0008273 | calcium, potassium:sodium antiporter activity(GO:0008273) |
0.2 | 0.9 | GO:0046790 | virion binding(GO:0046790) |
0.2 | 0.5 | GO:0035241 | protein-arginine omega-N monomethyltransferase activity(GO:0035241) |
0.2 | 0.9 | GO:0042979 | ornithine decarboxylase regulator activity(GO:0042979) |
0.2 | 0.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.2 | 0.5 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.2 | 0.5 | GO:0050510 | N-acetylgalactosaminyl-proteoglycan 3-beta-glucuronosyltransferase activity(GO:0050510) |
0.2 | 0.4 | GO:0043120 | tumor necrosis factor binding(GO:0043120) |
0.2 | 0.5 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.2 | 0.5 | GO:0015182 | L-asparagine transmembrane transporter activity(GO:0015182) L-glutamine transmembrane transporter activity(GO:0015186) |
0.2 | 1.5 | GO:0031005 | filamin binding(GO:0031005) |
0.2 | 1.3 | GO:0004017 | adenylate kinase activity(GO:0004017) |
0.2 | 2.9 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
0.2 | 0.3 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 1.5 | GO:0005247 | voltage-gated chloride channel activity(GO:0005247) |
0.2 | 0.3 | GO:0030519 | snoRNP binding(GO:0030519) |
0.2 | 1.3 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.2 | 0.3 | GO:0010521 | telomerase inhibitor activity(GO:0010521) |
0.2 | 14.7 | GO:0005179 | hormone activity(GO:0005179) |
0.2 | 0.6 | GO:0004031 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.2 | 0.8 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.3 | GO:0043121 | neurotrophin binding(GO:0043121) |
0.2 | 0.8 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) |
0.2 | 0.2 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.2 | 0.6 | GO:0070883 | pre-miRNA binding(GO:0070883) |
0.2 | 1.9 | GO:0004865 | protein serine/threonine phosphatase inhibitor activity(GO:0004865) |
0.2 | 1.1 | GO:0005338 | nucleotide-sugar transmembrane transporter activity(GO:0005338) |
0.2 | 0.5 | GO:0004814 | arginine-tRNA ligase activity(GO:0004814) |
0.2 | 6.0 | GO:0005080 | protein kinase C binding(GO:0005080) |
0.1 | 3.0 | GO:0051721 | protein phosphatase 2A binding(GO:0051721) |
0.1 | 0.1 | GO:0042166 | acetylcholine binding(GO:0042166) |
0.1 | 0.9 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
0.1 | 0.7 | GO:0016775 | creatine kinase activity(GO:0004111) phosphotransferase activity, nitrogenous group as acceptor(GO:0016775) |
0.1 | 1.5 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.1 | 0.4 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.1 | 0.6 | GO:0071614 | linoleic acid epoxygenase activity(GO:0071614) |
0.1 | 2.0 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.1 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 0.4 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.1 | 3.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.1 | 0.3 | GO:0016615 | malate dehydrogenase activity(GO:0016615) |
0.1 | 0.4 | GO:0050694 | galactose 3-O-sulfotransferase activity(GO:0050694) |
0.1 | 0.4 | GO:0035514 | DNA demethylase activity(GO:0035514) |
0.1 | 8.6 | GO:0008201 | heparin binding(GO:0008201) |
0.1 | 0.4 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.1 | 0.1 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.1 | 0.3 | GO:1990825 | sequence-specific mRNA binding(GO:1990825) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 0.6 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.1 | 0.5 | GO:0005173 | stem cell factor receptor binding(GO:0005173) |
0.1 | 0.4 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.1 | 4.7 | GO:1990782 | protein tyrosine kinase binding(GO:1990782) |
0.1 | 0.1 | GO:0038100 | nodal binding(GO:0038100) |
0.1 | 0.4 | GO:0098634 | protein binding involved in cell-matrix adhesion(GO:0098634) |
0.1 | 0.4 | GO:0031694 | alpha-2A adrenergic receptor binding(GO:0031694) |
0.1 | 1.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.1 | 0.4 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
0.1 | 0.6 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.1 | 2.2 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.1 | 0.1 | GO:0070815 | peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.1 | 0.4 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
0.1 | 0.4 | GO:0042805 | actinin binding(GO:0042805) |
0.1 | 1.4 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.1 | 1.5 | GO:0008143 | poly(A) binding(GO:0008143) |
0.1 | 0.2 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.1 | 0.3 | GO:0030943 | mitochondrion targeting sequence binding(GO:0030943) |
0.1 | 0.6 | GO:0070679 | inositol 1,4,5 trisphosphate binding(GO:0070679) |
0.1 | 0.7 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 1.1 | GO:0070180 | large ribosomal subunit rRNA binding(GO:0070180) |
0.1 | 0.2 | GO:0003997 | acyl-CoA oxidase activity(GO:0003997) |
0.1 | 0.4 | GO:0048019 | receptor antagonist activity(GO:0048019) |
0.1 | 1.8 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.1 | 0.1 | GO:0034452 | dynactin binding(GO:0034452) |
0.1 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.1 | 0.1 | GO:0038181 | bile acid receptor activity(GO:0038181) |
0.1 | 0.8 | GO:0022829 | wide pore channel activity(GO:0022829) |
0.1 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.1 | 0.9 | GO:0015301 | anion:anion antiporter activity(GO:0015301) |
0.1 | 0.2 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
0.1 | 0.5 | GO:0045545 | syndecan binding(GO:0045545) |
0.1 | 0.3 | GO:0061665 | SUMO ligase activity(GO:0061665) |
0.1 | 0.5 | GO:0004565 | beta-galactosidase activity(GO:0004565) |
0.1 | 2.2 | GO:0019212 | phosphatase inhibitor activity(GO:0019212) |
0.1 | 0.4 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.1 | 0.2 | GO:0032190 | acrosin binding(GO:0032190) |
0.1 | 0.9 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.1 | 3.3 | GO:0004027 | alcohol sulfotransferase activity(GO:0004027) |
0.1 | 1.2 | GO:0001637 | G-protein coupled chemoattractant receptor activity(GO:0001637) chemokine receptor activity(GO:0004950) |
0.1 | 0.4 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.1 | 0.6 | GO:0008420 | CTD phosphatase activity(GO:0008420) |
0.1 | 0.6 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.1 | 2.6 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.1 | 0.4 | GO:0001228 | transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding(GO:0001228) |
0.1 | 0.9 | GO:0023026 | MHC class II protein complex binding(GO:0023026) |
0.1 | 0.6 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.1 | 0.3 | GO:0046975 | histone methyltransferase activity (H3-K36 specific)(GO:0046975) |
0.1 | 0.3 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
0.1 | 0.3 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 0.8 | GO:0004955 | prostaglandin receptor activity(GO:0004955) |
0.1 | 0.4 | GO:0001609 | G-protein coupled adenosine receptor activity(GO:0001609) |
0.1 | 0.3 | GO:0004126 | cytidine deaminase activity(GO:0004126) |
0.1 | 0.3 | GO:0052834 | inositol monophosphate 1-phosphatase activity(GO:0008934) inositol monophosphate 3-phosphatase activity(GO:0052832) inositol monophosphate 4-phosphatase activity(GO:0052833) inositol monophosphate phosphatase activity(GO:0052834) |
0.1 | 1.1 | GO:0055103 | ligase regulator activity(GO:0055103) |
0.1 | 1.2 | GO:0043395 | heparan sulfate proteoglycan binding(GO:0043395) |
0.1 | 0.3 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
0.1 | 1.1 | GO:0005355 | glucose transmembrane transporter activity(GO:0005355) |
0.1 | 1.0 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
0.1 | 0.4 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
0.1 | 0.1 | GO:0008158 | hedgehog receptor activity(GO:0008158) |
0.1 | 0.6 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
0.1 | 0.6 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.1 | 0.2 | GO:0070840 | dynein complex binding(GO:0070840) |
0.1 | 0.1 | GO:0031802 | type 5 metabotropic glutamate receptor binding(GO:0031802) |
0.1 | 0.1 | GO:0070905 | serine binding(GO:0070905) |
0.1 | 3.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.1 | 0.4 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
0.1 | 0.6 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) |
0.1 | 0.3 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.1 | 0.5 | GO:0031402 | sodium ion binding(GO:0031402) |
0.1 | 0.4 | GO:0050542 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
0.1 | 1.3 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
0.1 | 0.2 | GO:0008147 | structural constituent of bone(GO:0008147) |
0.1 | 1.3 | GO:0019198 | transmembrane receptor protein phosphatase activity(GO:0019198) |
0.1 | 0.1 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.1 | 0.2 | GO:0004813 | alanine-tRNA ligase activity(GO:0004813) |
0.1 | 0.2 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.1 | 0.3 | GO:0043495 | protein anchor(GO:0043495) |
0.1 | 0.1 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
0.1 | 1.5 | GO:0005251 | delayed rectifier potassium channel activity(GO:0005251) |
0.1 | 0.3 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 0.1 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.1 | 0.2 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 0.7 | GO:0042923 | neuropeptide binding(GO:0042923) |
0.1 | 0.1 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.1 | 0.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.1 | 1.9 | GO:0005518 | collagen binding(GO:0005518) |
0.1 | 0.8 | GO:0046332 | SMAD binding(GO:0046332) |
0.1 | 0.9 | GO:0005539 | glycosaminoglycan binding(GO:0005539) |
0.0 | 0.1 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.3 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.0 | 0.2 | GO:0001849 | complement component C1q binding(GO:0001849) |
0.0 | 0.4 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.0 | 0.3 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.1 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
0.0 | 0.0 | GO:0035240 | dopamine binding(GO:0035240) |
0.0 | 0.0 | GO:1990430 | extracellular matrix protein binding(GO:1990430) |
0.0 | 0.2 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
0.0 | 0.3 | GO:0050780 | dopamine receptor binding(GO:0050780) |
0.0 | 0.2 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.0 | 0.8 | GO:0004890 | GABA-A receptor activity(GO:0004890) |
0.0 | 0.5 | GO:0005451 | monovalent cation:proton antiporter activity(GO:0005451) |
0.0 | 0.1 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
0.0 | 0.0 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.0 | 0.7 | GO:0035410 | dihydrotestosterone 17-beta-dehydrogenase activity(GO:0035410) |
0.0 | 0.1 | GO:0010484 | H3 histone acetyltransferase activity(GO:0010484) |
0.0 | 0.1 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
0.0 | 0.1 | GO:0016833 | oxo-acid-lyase activity(GO:0016833) |
0.0 | 0.2 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.0 | 0.4 | GO:0051787 | misfolded protein binding(GO:0051787) |
0.0 | 0.5 | GO:0043274 | phospholipase binding(GO:0043274) |
0.0 | 0.8 | GO:0016709 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen(GO:0016709) |
0.0 | 0.1 | GO:0031404 | chloride ion binding(GO:0031404) |
0.0 | 0.1 | GO:0030151 | molybdenum ion binding(GO:0030151) |
0.0 | 0.1 | GO:1904288 | BAT3 complex binding(GO:1904288) |
0.0 | 1.4 | GO:0001653 | peptide receptor activity(GO:0001653) |
0.0 | 0.1 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.0 | 2.1 | GO:0051015 | actin filament binding(GO:0051015) |
0.0 | 4.2 | GO:0003779 | actin binding(GO:0003779) |
0.0 | 0.2 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.0 | 0.0 | GO:0034483 | heparan sulfate sulfotransferase activity(GO:0034483) |
0.0 | 3.5 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.4 | GO:0030332 | cyclin binding(GO:0030332) |
0.0 | 0.8 | GO:0008527 | taste receptor activity(GO:0008527) |
0.0 | 0.1 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.0 | 0.1 | GO:0051033 | nucleic acid transmembrane transporter activity(GO:0051032) RNA transmembrane transporter activity(GO:0051033) |
0.0 | 0.0 | GO:0043426 | MRF binding(GO:0043426) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0003909 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
0.0 | 0.1 | GO:0034842 | 3-oxo-2-(2'-pentenyl)cyclopentane-1-octanoic acid CoA ligase activity(GO:0010435) 3-isopropenyl-6-oxoheptanoyl-CoA synthetase activity(GO:0018854) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA synthetase activity(GO:0018855) benzoyl acetate-CoA ligase activity(GO:0018856) 2,4-dichlorobenzoate-CoA ligase activity(GO:0018857) pivalate-CoA ligase activity(GO:0034783) cyclopropanecarboxylate-CoA ligase activity(GO:0034793) adipate-CoA ligase activity(GO:0034796) citronellyl-CoA ligase activity(GO:0034823) mentha-1,3-dione-CoA ligase activity(GO:0034841) thiophene-2-carboxylate-CoA ligase activity(GO:0034842) 2,4,4-trimethylpentanoate-CoA ligase activity(GO:0034865) cis-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034942) trans-2-methyl-5-isopropylhexa-2,5-dienoate-CoA ligase activity(GO:0034943) branched-chain acyl-CoA synthetase (ADP-forming) activity(GO:0043759) aryl-CoA synthetase (ADP-forming) activity(GO:0043762) 3-hydroxypropionyl-CoA synthetase activity(GO:0043955) perillic acid:CoA ligase (ADP-forming) activity(GO:0052685) perillic acid:CoA ligase (AMP-forming) activity(GO:0052686) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (ADP-forming) activity(GO:0052687) (3R)-3-isopropenyl-6-oxoheptanoate:CoA ligase (AMP-forming) activity(GO:0052688) pristanate-CoA ligase activity(GO:0070251) malonyl-CoA synthetase activity(GO:0090409) |
0.0 | 0.0 | GO:0050309 | glucose-6-phosphatase activity(GO:0004346) sugar-terminal-phosphatase activity(GO:0050309) |
0.0 | 0.1 | GO:0008821 | crossover junction endodeoxyribonuclease activity(GO:0008821) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.0 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.0 | 0.4 | GO:0004772 | sterol O-acyltransferase activity(GO:0004772) |
0.0 | 0.0 | GO:0032564 | dATP binding(GO:0032564) |
0.0 | 0.1 | GO:0004396 | glucokinase activity(GO:0004340) hexokinase activity(GO:0004396) |
0.0 | 0.0 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
0.0 | 0.0 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
0.0 | 0.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.3 | 3.3 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
1.4 | 39.5 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
1.3 | 56.6 | NABA COLLAGENS | Genes encoding collagen proteins |
1.2 | 6.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
1.0 | 11.4 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.7 | 0.7 | PID VEGFR1 PATHWAY | VEGFR1 specific signals |
0.7 | 8.2 | PID ALK2 PATHWAY | ALK2 signaling events |
0.6 | 4.5 | PID ALK1 PATHWAY | ALK1 signaling events |
0.5 | 17.2 | PID BMP PATHWAY | BMP receptor signaling |
0.5 | 4.5 | PID NEPHRIN NEPH1 PATHWAY | Nephrin/Neph1 signaling in the kidney podocyte |
0.5 | 5.4 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.5 | 32.8 | WNT SIGNALING | Genes related to Wnt-mediated signal transduction |
0.5 | 21.4 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
0.4 | 5.4 | PID PS1 PATHWAY | Presenilin action in Notch and Wnt signaling |
0.4 | 7.9 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.4 | 11.7 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
0.4 | 12.4 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 0.4 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.4 | 7.4 | PID HEDGEHOG 2PATHWAY | Signaling events mediated by the Hedgehog family |
0.4 | 2.5 | SA TRKA RECEPTOR | The TrkA receptor binds nerve growth factor to activate MAP kinase pathways and promote cell growth. |
0.4 | 7.8 | PID NETRIN PATHWAY | Netrin-mediated signaling events |
0.4 | 1.2 | PID VEGF VEGFR PATHWAY | VEGF and VEGFR signaling network |
0.4 | 9.2 | PID EPHA FWDPATHWAY | EPHA forward signaling |
0.4 | 2.7 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
0.4 | 62.4 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.4 | 10.0 | PID EPHRINB REV PATHWAY | Ephrin B reverse signaling |
0.4 | 6.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
0.4 | 8.2 | PID NCADHERIN PATHWAY | N-cadherin signaling events |
0.4 | 11.6 | PID AJDISS 2PATHWAY | Posttranslational regulation of adherens junction stability and dissassembly |
0.4 | 8.6 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
0.3 | 0.3 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
0.3 | 2.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
0.3 | 4.3 | PID EPHB FWD PATHWAY | EPHB forward signaling |
0.3 | 0.6 | PID S1P S1P2 PATHWAY | S1P2 pathway |
0.3 | 1.9 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
0.3 | 8.8 | PID BETA CATENIN NUC PATHWAY | Regulation of nuclear beta catenin signaling and target gene transcription |
0.2 | 1.2 | PID IL3 PATHWAY | IL3-mediated signaling events |
0.2 | 31.8 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.2 | 3.0 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.2 | 1.3 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.2 | 0.4 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.2 | 1.2 | PID SYNDECAN 3 PATHWAY | Syndecan-3-mediated signaling events |
0.2 | 6.5 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.2 | 0.4 | PID TRAIL PATHWAY | TRAIL signaling pathway |
0.2 | 2.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.2 | 7.1 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
0.2 | 4.2 | PID DELTA NP63 PATHWAY | Validated transcriptional targets of deltaNp63 isoforms |
0.2 | 40.8 | NABA SECRETED FACTORS | Genes encoding secreted soluble factors |
0.2 | 0.7 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.2 | 2.1 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.2 | 0.5 | PID PI3K PLC TRK PATHWAY | Trk receptor signaling mediated by PI3K and PLC-gamma |
0.1 | 0.4 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.1 | 4.5 | PID ILK PATHWAY | Integrin-linked kinase signaling |
0.1 | 0.3 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
0.1 | 27.8 | NABA MATRISOME ASSOCIATED | Ensemble of genes encoding ECM-associated proteins including ECM-affilaited proteins, ECM regulators and secreted factors |
0.1 | 1.9 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.1 | 0.3 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
0.1 | 4.0 | NABA MATRISOME | Ensemble of genes encoding extracellular matrix and extracellular matrix-associated proteins |
0.1 | 0.1 | PID INTEGRIN5 PATHWAY | Beta5 beta6 beta7 and beta8 integrin cell surface interactions |
0.1 | 1.8 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
0.1 | 0.8 | PID IGF1 PATHWAY | IGF1 pathway |
0.1 | 0.1 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.1 | 1.6 | SIG CD40PATHWAYMAP | Genes related to CD40 signaling |
0.1 | 2.4 | PID ENDOTHELIN PATHWAY | Endothelins |
0.1 | 1.2 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.1 | 0.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.1 | 0.3 | PID NFKAPPAB ATYPICAL PATHWAY | Atypical NF-kappaB pathway |
0.1 | 1.6 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.1 | 1.2 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.0 | 0.0 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.0 | 0.1 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.0 | 0.3 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.1 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.0 | 0.3 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
0.0 | 0.5 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.0 | 1.2 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
0.0 | 0.6 | PID RAC1 REG PATHWAY | Regulation of RAC1 activity |
0.0 | 0.2 | PID CDC42 REG PATHWAY | Regulation of CDC42 activity |
0.0 | 0.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.0 | 0.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.0 | 0.1 | PID GLYPICAN 1PATHWAY | Glypican 1 network |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.0 | 3.0 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
1.7 | 1.7 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |
1.5 | 41.0 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
1.3 | 18.2 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.2 | 64.5 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
1.1 | 24.0 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
1.1 | 12.9 | REACTOME FGFR2C LIGAND BINDING AND ACTIVATION | Genes involved in FGFR2c ligand binding and activation |
1.0 | 1.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.9 | 19.5 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
0.8 | 11.0 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 2.9 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
0.7 | 11.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.7 | 2.2 | REACTOME SIGNALING BY FGFR | Genes involved in Signaling by FGFR |
0.7 | 2.0 | REACTOME CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES | Genes involved in Cross-presentation of soluble exogenous antigens (endosomes) |
0.7 | 55.0 | REACTOME CLASS B 2 SECRETIN FAMILY RECEPTORS | Genes involved in Class B/2 (Secretin family receptors) |
0.6 | 2.3 | REACTOME ACTIVATED POINT MUTANTS OF FGFR2 | Genes involved in Activated point mutants of FGFR2 |
0.5 | 5.4 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.5 | 0.5 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.5 | 14.6 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.5 | 4.6 | REACTOME SEMA3A PLEXIN REPULSION SIGNALING BY INHIBITING INTEGRIN ADHESION | Genes involved in SEMA3A-Plexin repulsion signaling by inhibiting Integrin adhesion |
0.5 | 8.7 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
0.4 | 10.1 | REACTOME NETRIN1 SIGNALING | Genes involved in Netrin-1 signaling |
0.4 | 4.9 | REACTOME CS DS DEGRADATION | Genes involved in CS/DS degradation |
0.4 | 4.1 | REACTOME RECEPTOR LIGAND BINDING INITIATES THE SECOND PROTEOLYTIC CLEAVAGE OF NOTCH RECEPTOR | Genes involved in Receptor-ligand binding initiates the second proteolytic cleavage of Notch receptor |
0.4 | 4.4 | REACTOME PRESYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Presynaptic nicotinic acetylcholine receptors |
0.4 | 3.6 | REACTOME SIGNALING BY NODAL | Genes involved in Signaling by NODAL |
0.3 | 0.7 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
0.3 | 4.3 | REACTOME INCRETIN SYNTHESIS SECRETION AND INACTIVATION | Genes involved in Incretin Synthesis, Secretion, and Inactivation |
0.3 | 6.6 | REACTOME ADHERENS JUNCTIONS INTERACTIONS | Genes involved in Adherens junctions interactions |
0.3 | 3.1 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.3 | 7.0 | REACTOME NITRIC OXIDE STIMULATES GUANYLATE CYCLASE | Genes involved in Nitric oxide stimulates guanylate cyclase |
0.3 | 1.5 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.3 | 5.3 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.3 | 12.7 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.3 | 3.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.3 | 2.5 | REACTOME P75NTR RECRUITS SIGNALLING COMPLEXES | Genes involved in p75NTR recruits signalling complexes |
0.3 | 2.3 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.3 | 5.8 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.3 | 2.0 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.3 | 0.8 | REACTOME ARMS MEDIATED ACTIVATION | Genes involved in ARMS-mediated activation |
0.2 | 2.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.2 | 1.7 | REACTOME SIGNALLING TO RAS | Genes involved in Signalling to RAS |
0.2 | 6.0 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.2 | 1.8 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.2 | 0.4 | REACTOME CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6 | Genes involved in CDK-mediated phosphorylation and removal of Cdc6 |
0.2 | 0.6 | REACTOME CLEAVAGE OF GROWING TRANSCRIPT IN THE TERMINATION REGION | Genes involved in Cleavage of Growing Transcript in the Termination Region |
0.2 | 0.8 | REACTOME CELL JUNCTION ORGANIZATION | Genes involved in Cell junction organization |
0.2 | 1.4 | REACTOME TRANSLOCATION OF ZAP 70 TO IMMUNOLOGICAL SYNAPSE | Genes involved in Translocation of ZAP-70 to Immunological synapse |
0.2 | 0.6 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.2 | 2.6 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.2 | 0.2 | REACTOME IL 3 5 AND GM CSF SIGNALING | Genes involved in Interleukin-3, 5 and GM-CSF signaling |
0.2 | 1.4 | REACTOME DEFENSINS | Genes involved in Defensins |
0.2 | 1.5 | REACTOME KERATAN SULFATE DEGRADATION | Genes involved in Keratan sulfate degradation |
0.2 | 1.1 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.2 | 0.8 | REACTOME CD28 DEPENDENT PI3K AKT SIGNALING | Genes involved in CD28 dependent PI3K/Akt signaling |
0.2 | 6.4 | REACTOME HEPARAN SULFATE HEPARIN HS GAG METABOLISM | Genes involved in Heparan sulfate/heparin (HS-GAG) metabolism |
0.1 | 1.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
0.1 | 6.3 | REACTOME VOLTAGE GATED POTASSIUM CHANNELS | Genes involved in Voltage gated Potassium channels |
0.1 | 1.4 | REACTOME BASE FREE SUGAR PHOSPHATE REMOVAL VIA THE SINGLE NUCLEOTIDE REPLACEMENT PATHWAY | Genes involved in Base-free sugar-phosphate removal via the single-nucleotide replacement pathway |
0.1 | 0.4 | REACTOME G BETA GAMMA SIGNALLING THROUGH PLC BETA | Genes involved in G beta:gamma signalling through PLC beta |
0.1 | 5.9 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.1 | 0.3 | REACTOME PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA | Genes involved in Processing of Capped Intron-Containing Pre-mRNA |
0.1 | 1.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.1 | 0.4 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
0.1 | 0.1 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
0.1 | 2.3 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.1 | 1.0 | REACTOME OPSINS | Genes involved in Opsins |
0.1 | 12.4 | REACTOME PEPTIDE LIGAND BINDING RECEPTORS | Genes involved in Peptide ligand-binding receptors |
0.1 | 1.3 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
0.1 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.1 | 0.3 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
0.1 | 0.3 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.1 | 0.5 | REACTOME SHC MEDIATED CASCADE | Genes involved in SHC-mediated cascade |
0.1 | 0.9 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.1 | 0.9 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
0.1 | 0.2 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.1 | 0.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 0.1 | REACTOME HIGHLY CALCIUM PERMEABLE POSTSYNAPTIC NICOTINIC ACETYLCHOLINE RECEPTORS | Genes involved in Highly calcium permeable postsynaptic nicotinic acetylcholine receptors |
0.1 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.1 | 0.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.1 | 1.0 | REACTOME ACYL CHAIN REMODELLING OF PE | Genes involved in Acyl chain remodelling of PE |
0.0 | 0.0 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
0.0 | 1.4 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
0.0 | 0.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
0.0 | 0.8 | REACTOME REGULATION OF BETA CELL DEVELOPMENT | Genes involved in Regulation of beta-cell development |
0.0 | 0.3 | REACTOME CLASS C 3 METABOTROPIC GLUTAMATE PHEROMONE RECEPTORS | Genes involved in Class C/3 (Metabotropic glutamate/pheromone receptors) |
0.0 | 0.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
0.0 | 0.4 | REACTOME CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM | Genes involved in Chondroitin sulfate/dermatan sulfate metabolism |
0.0 | 0.2 | REACTOME CIRCADIAN REPRESSION OF EXPRESSION BY REV ERBA | Genes involved in Circadian Repression of Expression by REV-ERBA |
0.0 | 0.0 | REACTOME CTLA4 INHIBITORY SIGNALING | Genes involved in CTLA4 inhibitory signaling |
0.0 | 0.6 | REACTOME KINESINS | Genes involved in Kinesins |
0.0 | 0.0 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
0.0 | 1.5 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.0 | 0.0 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
0.0 | 0.1 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.0 | 0.0 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |